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CHAPTER I 
Introduction 
1.1 The Lycopodium alkaloids 
The Lycopodium alkaloids are a large group of natural products characterized 
by their unique polycyclic frameworks.
1,2
 These alkaloids derive their name from the 
Lycopodium species of clubmosses from which they were originally isolated.
3
 The 
Lycopodium alkaloids are divided into four distinct structural classes; the 
fawcettimine class, the lycopodine class, the lycodine class and the miscellaneous 
class (Figure 1). Hydrindane containing natural products, such as sieboldine A 1, 
alopecuridine 2 and fawcettimine 3 are classified in the fawcettimine group. Natural 
products that contain a pyridine or pyridone ring, such as huperzine A 4, are classified 
in the lycodine group. Furthermore, alkaloids that contain four interconnected six-
membered rings, such as lycopodine 5, are members of the lycopodine group. Finally, 
natural products that are devoid of one of the aforementioned structural features are 




Figure 1. Representative Lycopodium Alkaloids. 
  1
  2  
 
 
1.1.1 Structure and biological activity of (+)-sieboldine A  
In 2003, Kobayashi and coworkers reported the isolation of (+)-sieboldine A 1 
from the clubmoss Lycopodium sieboldii in Japan. Structurally, sieboldine A 1 
contains unprecedented fused tetracyclic skeleton consisting of cis-hydrindane ring 
system, the distinctive structural feature of fawcettimine-type Lycopodium alkaloids 
and N-hydroxyazacyclononane ring embedded in a bicyclo[5.2.1]decane-N,O-acetal. 
(+)-Sieboldine A 1 has two contiguous quaternary carbons; one of them is an all-




Figure 2. Structure of (+)-sieboldine A 1. 
 Along with their complex structures, the Lycopodium alkaloids generally have 
interesting biological activities and plants or plant extracts containing these alkaloids 
have been utilized in traditional folk medicine for decades.
1
 Sieboldine A 1 exhibited 
in vitro cytotoxicity against murine lymphoma L1210 cells (IC50 5.1 µg/mL) and 
inhibited acetylcholinesterase (from electric eel) with an IC50 value of 2.0 µM, which 
was comparable to that of huperzine A 4.
5
 In clinical trials, Huperzine A 4 has been 
shown to have beneficial effects on cognitive function and memory in patients with 
Alzheimer's disease.
6,7
 The unusual unique skeletons  along with the interesting 




1.1.2 Strategic comparison of previously reported syntheses of sieboldine A    
The completion of the first total synthesis of (+)-sieboldine A 1 was reported 
in 2010 by Overman.
18,19
 Later, Tu and coworkers reported the first total synthesis of 
alopecuridine 2 and its biomimetic oxidation to sieboldine A 1.
20,21
 Overman and Tu 
used two completely different strategies to access sieboldine A 1. The only common 
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idea shared by the two strategies was the elaboration of the sensitive N,O-acetal 
moiety at a late stage of the synthesis.  
Overman assembled the N,O-acetal via intramolecular coupling of the 
activated thioglycoside moiety with the tethered hydroxylamine side chain in 
derivative 7 (Scheme 1). The cis-hydrindanone 8 was obtained by a pinacol-
terminated Prins cyclization of enyne 9 as a key step. Enyne 9 was prepared from 
cyclopentanone 10 through vinyl addition and alkyne elongation. Cyclopentanone 10 
was readily accessed from previously reported enantiomerically pure bicyclic lactone 
11. 
 
Scheme 1: Overman's retrosynthetic analysis of (+)-sieboldine A 1. 
Tu decided to follow Kobayashi’s proposed biogenetic pathway and expected 
that formation of the tetrahydrofuran ring with concomitant formation of the N,O-
acetal could be achieved through a two-step oxidation of alopecuridine 2 (Scheme 2). 
The B-ring of the alkaloid was obtained via SmI2-mediated pinacol coupling of 
compound 12. The all-carbon quaternary center at C12 and the aza-cyclononane ring 
were constructed through a semipinacol ring expansion of the eight-membered 
nitrogen-containing ring of 13. Hydroxy epoxide 13 was prepared from haloalkene 14 
and carbamate 15 by coupling and epoxidation. 




Scheme 2: Tu's retrosynthetic analysis of (+)-sieboldine A 1. 
1.1.3 Total synthesis of (+)-sieboldine A by Overman 
The key step in Overman's preparation of (+)-sieboldine A 1 was a pinacol-
terminated cyclization cascade (Scheme 3).  The synthetic pathway started with a 
methyl cuprate-promoted SN2′ alkylation of lactone 11, followed by iodolactonization 
to give iodolactone 16 in 93% yield. Next, lithium aluminum hydride (LAH) 
reduction of 16 led to the corresponding dehalogenated diol, which was selectively 
monosilylated and oxidized with Dess-Martin periodinane (DMP) to form ketone 17. 
Addition of E-vinyl iodide derivative 18 to ketone 17 afforded the desired allylic 
alcohol 19 in 90% yield. Thus, silylation of the allylic hydroxy functionality of 19 
followed by Swern oxidation of the primary silyl ether, and subsequent reaction with 
the Bestmann–Ohira reagent 20 afforded alkyne 21 in 70% yield. Alkyne 21 was 
subjected to a gold-catalyzed pinacol-type cyclization reaction to deliver cis-
hydrindanone 23 in 78% yield. 




Scheme 3: Overman's total synthesis of  (+)-sieboldine A 1. 
The next steps were concerned with the construction of the tetrahydrofuran 
moiety. Ozonolytic cleavage of the exo-methylene functionality of 23 and subsequent 
base-promoted elimination of the phenoxide afforded enone 24. Europium(III)-
catalyzed hetero Diels-Alder reaction with ethyl vinyl ether furnished the tricyclic 
dihydropyran 25. Reduction of the C13 carbonyl group followed by oxidation with 
dimethyldioxirane (DMDO) and treatment with BF3.OEt2 and ethanethiol afforded 
cyclic hemithioacetal 26 in 53% yield. 
Desilylation of 26 was carried out with TBAF and the resulting primary 
alcohol was subjected to a Mitsunobu coupling with protected hydroxylamine 
derivative (NsNH-OMOM). Then, the nosyl protecting group was removed with 
thiophenolate and treatment with dimethyl(methylthio)sulfonium triflate  (DMTST) in 
the presence of 2,6-di-tert-butyl-4-methylpyridine (DTBMP) afforded  the pentacyclic 
azacyclononane 27 in 39% yield. Final oxidation and MOM deprotection delivered 








1.1.4 Total synthesis of (+)-sieboldine A by Tu 
The plausible biogenesis of (+)-sieboldine A 1 was initially proposed by 
Kobayashi (Scheme 4). Alopecuridine 2 may exist in either an aminoacetal form or an 
amino ketone form. The aminoacetal form of 2 was confirmed by X-ray analysis. 
SieboldineA 1 might be generated from alopecuridine 2 as follows. Cleavage of the 
C13-N1 bond of an N-oxidative product of 2 followed by Polonovski-type reaction 
(path a) might result in an iminium intermediate A with a nine-membered ring system, 
although an alternative path through a hydroxylamine derivative B is also possible 
(path b). Oxidation of the imine A to produce an oxaziridine ring or a nitrone 
followed by attack of the hydroxy group at C4 to C1 will give (+)-sieboldine A 1, 




Scheme 4: Kobayashi's proposed biogenesis of (+)-sieboldine A 1. 
Tu and coworkers followed Kobayashi’s proposed biogenetic pathway and 
used alopecuridine 2 as a synthetic scaffold to access sieboldine A 1 (Scheme 5).
20,21
 
The synthesis was commenced by treatment of  trans-cyclohexenol 28 with trimethyl 
orthoester at 165 °C and the generated ester was reduced by LAH followed by Dess-
Martin oxidation and Wittig methylenation to produce bromoalkene derivative 29 in  
52% yield with a dr of 5:1. The known ketone 15 was prepared from azepine 30 via a 
Tiffenau–Demjanov-type reaction followed by hydrolysis of the ethyl ester and 
subsequent decarboxylation. Coupling of 29 with 15 was carried out through the 
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intermediacy of the vinylcerium species generated from the lithium salt of 29. To 
avoid elimination, the generated coupling product was directly epoxidized by m-
CPBA resulting in formation of epoxides 12 and 12' as an inseparable mixture in 71% 
yield with a dr of 6:1. The semipinacol rearrangement of 12 and 12' promoted by 
BF3.OEt2 took place to produce ketones 13 and 13' in 51% yield.   After a three-step 
sequence involving hydroxyl group protection, ozonolysis, and SmI2 promoted 
Intramolecular pinacol coupling, the so obtained tricyclic compound 31 was further 
subjected to one-pot deprotection, TPAP oxidation and final N-Boc deprotection to 
deliver (+)-alopecuridine TFA 2 in 23% yield from 13.  
The biomimetic transformation of (+)-alopecuridine TFA 2 to (+)-sieboldine 
A 1 was realized through a two-step one pot oxidation cascade. Alopecuridine TFA 2 
was oxidized to N-oxide 32 by the peroxide agent. The N-oxide 32 might isomerize to 
N-hydroxide 33 which underwent further oxidation with HgO to give nitrone 34. The 
Intramolecular nucleophilic attack of the C4 hydroxy group to C1 led to formation of 
the tetrahydrofuran ring and afforded (+)-sieboldine A 1 in 60% yield. 




Scheme 5: Tu's total synthesis of (+)-sieboldine A 1. 
1.2 Pauson-Khand Reaction (PKR) 
1.2.1 The Discovery and Early Evolution of the PKR  
Metal-mediated transformations have changed the profile and enhanced the 
potential of organic synthesis well beyond that which was previously possible or 
imaginable. The cycloaddition reaction is one of the most attractive synthetic 
protocols for accessing a variety of scientifically interesting and pharmaceutically 
useful ring skeletons from simple starting materials.
22
 In 1973, Pauson and Khand 
reported the formal [2+2+1] cycloaddition reaction between an alkyne, an alkene, and 
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carbon monoxide that has become one of the most elegant methods for the 




Scheme 6: Pauson-Khand reaction 
The first reported example was the reaction of norbornadiene 36 with the 
phenylacetylene-dicobalthexacarbonyl complex 35 to form the corresponding 




Scheme 7: First example of PKR 
The initial scope and generality of this cyclopentannulation process was 
established through an extensive series of studies by Pauson and his co-workers.
25-27
 
However, there were some limitations for the original PKR at that early stage. For 
example, the stoichiometric amount of catalyst and only strained olefins reacted 
efficiently under the original reaction conditions. With respect to regiochemistry of 
PKR, the larger alkyne substituent is being installed in the position α to the 





Scheme 8: Regiochemistry of the PKR 
1.2.2 Mechanism of the PKR 
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The mechanism of the PKR, initially proposed by Magnus, has now been 
widely accepted (Scheme 9). In the presence of Co2(CO)8 the alkyne 38 forms the 
tetrahedral dicobalt complex 39. After loss of CO, the alkene is coordinated to give 
complex 40, which undergoes insertion of the alkene moiety into the sterically least 
hindered Co-C bond to give complex 41. Subsequent CO insertion gives rise to the 
cobalt acyl complex 42. Extrusion of one Co(CO)3 fragment yields the 
cobaltacyclopropene complex 43, which is finally converted to the cyclopentenone 44 




Scheme 9: Mechanism of PKR 
1.2.3 Intramolecular PKR 
In 1981, Schore and co-workers reported the first example of an 
intramolecular PKR.
30
 This version provided a powerful methodology for 
construction of cyclopentenone fused bicyclic frameworks in a straightforward 
manner. Within the original landmark publication, both hept-6-en-1-ynes 45 and oct-
7-en-1-ynes  47 were utilized as substrates in intramolecular PK process to deliver 
bicyclo[3.3.0]octenones 46 andbicyclo[4.3.0]nonenone  48 (Scheme 10).
30
 




Scheme 10: Intramolecular PKR 
Later, Magnus further enhanced the efficacy of PKR by showing that 
appreciable stereoselectivity could be achieved within the intramolecular processes, a 
feature that proved to be the cornerstone to the application of the PKR in natural 
product synthesis.
31
 Substituents at the propargylic C3 position in 49 and allylic C5 
position in 52 have a preference to become situated on the exo-face and syn to the ring 
fusion hydrogen in the resulting bicyclic PK products 50 and 53 respectively (Scheme 





Scheme 11: Diastereoseletivity of intramolecular PKR. 
 With the stereochemical reaction outcomes established for a number of 
substrate substitution patterns, Magnus and co-workers utilized the intramolecular 





 and cytotoxic sesquiterpene, quadrone.
34
 
The intramolecular version of the PK annulation has continued to expand in 
terms of substrate scope and reaction selectivity. The growth in PK potential has been 
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driven by a range of emerging procedures using a variety of metal complexes and 




1.3 Total syntheses of Lycopodium alkaloids using intramolecular PKR    as a key 
step 
1.3.1 Total Syntheses of (+)-Lycoposerramine-C and (-)-phlegmariurine-A by 
Takayama 
In 2009, Takayama et al. reported the total synthesis of (+)-lycoposerramine-C 
60 and (-)-phlegmariurine-A 61 (Scheme 12).
45
 Amide 55 was stereoselectively 
prepared by a diastereoselective Hosomi-Sakurai allylation
46
 of 54 and subsequent 
cleavage of the oxazolidinone ring. Next, introduction of the alkyne chain to 55 
followed by a Corey-Bakshi-Shibata (CBS) reduction
47
 and TIPS protection of the 
resulting hydroxyl group afforded enyne 56 in 96% yield. The Intramolecular PKR of 
enyne 56 proceeded smoothly to form hydrindanone 57 in 87% yield. Construction of 
the quaternary center was conceived through a stereoselective CBS reduction of 57 
followed by sulfoxide formation and Claisen rearrangement to afford the desired 
aldehyde 58 in 51% yield. The tricyclic dione 59, obtained from 58 in 12 steps, was 
treated with ZnBr2 to form (+)-lycoposerramine-C 60 in 32 % yield from 58. 
Furthermore, base treatment of (+)-lycoposerramine-C 60 afforded (-)-
phlegmariurine-A 61 in 95% yield. 




Scheme 12: Takayama's total synthesis of (+)-lycoposerramine-C 60 and   (-)-
phlegmariurine-A 61. 
1.3.2 Total Syntheses of (-)-huperzine-Q, (+)-fawcettimine and (+)-fawcettidine 
by Takayama 
In 2011, Takayama and coworkers completed the first total synthesis of (-)-





 of ketone 62, followed by acid catalyzed 
cyclization gave lactone  63 in 68% yield with 83% ee. Allyl lactone 64, derived from 
63 in 2 steps, was reduced by LiBH4 to give enynediol 65 in 95% yield. Direct 
subjection of enynediol 65 to intramolecular PKR conditions resulted in formation of 
the undesired C7-epimer. Therefore, Takayama and coworkers decided to install a 
silicon tether to force the substrate in a chair-like conformation with the C15 side-
chain in axial position. With the silyl tether in place, PKR of enyne 66 and subsequent 
treatment with concentrated hydrochloric acid afforded the desired desilylated 
bicyclic Pauson-Khand product 67 in excellent yield. With bicyclic intermediate 67 in 
hand, takayama was able to access (-)-huperzine-Q 68 in 13 synthetic steps from 67 
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with an overall yield of 16.4%. In the next year, takayama reported the total synthesis 





Scheme 13: Takayama's total synthesis of (-)-huperzine Q 68, (+)-fawcettimine 3, 
(+)-fawcettidine 69. 
1.3.3 Total Syntheses of (-)-magellanine, (+)-magellaninone, and (+)-paniculatine  
by Mukai 
In 2007, Mukai reported the total syntheses of (-)-magellanine 77, (+)-
magellaninone 78, and (+)-paniculatine 79 from diethyl L-tartrate 70 in a 
stereoselective manner (Scheme 14).
51
 The crucial steps in these syntheses involved 
two intramolecular Pauson-Khand reactions and a Ueno-Stork reaction
52,53
 for 
construction of the quaternary center. Enyne 71, derived from diethyl L-tartarate 70, 
was subjected to an intramolecular PKR according to Sughihara's condition
54
 to give 
preferentially bicyclo[4.3.0]nonenone 72 in 92% yield. Selective deprotection of the 
C2-siloxy group of 72 with TBAF furnished alcohol 73 in 99% yield. The 
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simultaneous and stereoselective introduction of the essential carbon units at the C1 
position and the C9 position was realized by the Ueno-Stork reaction.  Alcohol 73 
was treated with ethyl 2-bromovinyl ether under  acidic catalysis, and the resulting 
bromoacetal derivative was subsequently subjected to AIBN in refluxing benzene in 
the presence of allyltributyltin to give the tricyclic lactone 74 in 65% yield. The enyne 
75, generated from 74, was subjected to a second intramolecular PKR to afford 
tetracyclic derivative 76 which finally converted to (-)-magellanine 61, (+)-
magellaninone 62 and (+)-paniculatine 63 in an overall yield 1.7, 1.9 and 2.8% 
respectively. 
 
Scheme 14: Mukai's Total Synthesis of (-)-magellanine 77, (+)-magellaninone 
78, and (+)-paniculatine 79. 
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1.3.4 Total Syntheses of (+)-fawcettimine and (+)-lycoposerramine B by Mukai 
Three years later, Mukai and coworkers utilized the lactone intermediate 74 
for the asymmetric preparation of (+)-fawcettimine 3 and (+)-lycoposerramine B 82 
(Scheme 15).
55
 The amide alcohol 80, derived from intermediate 74 in 11 synthetic 
steps, was subjected to an intramolecular Mitsunobu reaction
56
 to give tricyclic 
derivative 81 in 96% yield. The stereoselective introduction of C15 methyl and final 
conversions afforded (+)-fawcettimine 3 and (+)-lycoposerramine B 82 from tricyclic 
81 in 20 and 6% yield respectively. 
 
Scheme 15: Mukai's Total Synthesis of of (+)-fawcettimine 3 and (+)-
lycoposerramine B 82. 
The high stereoselective intramolecular PKR developed by Mukai for 
construction of the bicyclo[4.3.0] skeleton applied a nice protocol for the preparation 
of the cis-hydrindane moiety in fawcettimine-type Lycopodium alkaloids and enabled 
the access for several complex natural products from common precursors. However, 
the approach seemed to have two issues that needed to be improved. First, the 
conversion of diethyl L-tartrate 54 into the PKR substrate enyne 55 involved 10 
synthetic steps. Secondly, the stereoselective introduction of C15 methyl group 
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needed lengthy functional group manipulations which required several additional 
steps. 
1.3.5 Total Syntheses of (±) -fawcettimine, (±) -fawcettidine, (±) -
lycoposerramine-Q and (±)-lycoflexine  by Mukai 
In 2013, Mukai reported the total synthesis of new Lycopodium alkaloids using a 
more efficient second generation synthetic pathway for preparation of 
bicyclo[4.3.0]nonenone skeleton.
57
 In the improved protocol, Dienyne 84, generated 
from commercially available propargyl alcohol 83 in only 5 synthetic steps, was used 
as a substrate for the PKR. The intramolecular PKR of 84 afforded 
bicyclo[4.3.0]nonenone 85 in 86% yield with a dr of 10: 1. The exomethylene moiety 
was stereoselectively reduced by Wilkinson's hydrogenation to give the methyl 
derivative 86 with the required stereochemistry at C15 in 80% yield. The 
stereoselective creation of the quaternary center and introduction of allyl group α to 
the carbonyl group was achieved through the Ueno-Stork reaction to form cyclic 
acetal 87 in 73% yield. A cascade of reduction, benzyl protection, acid treatment and 
Wittig olefination gave the diallyl derivative 88 in 48% yield. The diallyl 88 was 
converted to the tricyclic derivative 90 in 7 synthetic steps with a Mitsunobu coupling 
reaction of diol 89 as a key step. With the common synthetic intermediate 90 in hand, 
final manipulations allowed the access of (±)-fawcettimine 3, (±)-fawcettidine 69, (±)-
lycoposerramine-Q 91 and (±)-lycoflexine 92. 




Scheme 16: Mukai's total syntheses of (±)-fawcettimine 3, (±)-fawcettidine 69, (±)-
lycoposerramine-Q 91 and (±)-lycoflexine 92. 
1.4 Research objective 
For the past century, the total synthesis of natural products has served as the 
flagship of chemical synthesis and the principal driving force for discovering new 
chemical reactivities, evaluating physical organic theories, testing the power of 
existing synthetic methods, and enabling biology and medicine to discover new drug 
candidates. The PKR has become one of the most important stratigies for the 
synthesis of cyclopentenone containing natural products. The intramolecular PKR of 
enynes, developed in Mukai's group, enabled the construction of 
bicyclo[4.3.0]nonenoe skeleton in a highly diastereoselective manner and allowed the 
access of several fawcettimine-type Lycopodium alkaloids. This research is concerned 
with the enantioselective total synthesis of (+)-sieboldine A 1 using an intramolecular 
PKR as a key step for construction of the cis-hydrindane core. (+)-Sieboldine A has 
  19  
 
 
interesting biological activities and providing a shorter and entatioselective route for 
its preparation from commercially available starting materials will help to explore its 
scaffold for the discovery of potential anti-Alzheimer agents.   
 










Results and Discussion 
2.1 Total synthesis of (±)-Sieboldine A 
2.1.1 Retrosynthetic analysis of (±)-Sieboldine A 
Our retrosynthetic plan for the preparation of (±)-sieboldine A 1 is presented 
in Scheme 18. The elaboration of the sensitive N,O-acetal functionality of (±)-1 was 
planned to be formed during the late stage of the synthesis via the intramolecular 
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displacement reaction of the lactol functionality of 93 by the O-protected 
hydroxylamine residue.
58,59
 The spirolactol framework of 93 would be formed 
through oxidative cyclization of the diol 94. Introduction of the nitrogen functionality 
could be achieved through the hydroboration−oxidation of the allyl side chain of 95, 
followed by a Mitsunobu coupling with the protected hydroxylamine derivative. The 
cis-hydrindanone 95 with all-carbon units required for 1 would be obtained by the 
consecutive bromoacetalization, Ueno−Stork cyclization, and Wittig olefination of 96. 
In our previous studies, we definitely showed that the PKR is a powerful and efficient 
synthetic tool to assemble bicyclo[4.3.0] frameworks.
55,57,60
 Based on our previous 
results, the PKR of the dienyne 97 would be expected to stereoselectively produce 96. 
Dienyne 97 would be available through a Barbier coupling of aldehyde 98 with a 
suitable allyl derivative. 
Scheme 18: Retrosynthetic analysis of (±)-Sieboldine A 1. 
2.1.2 Synthesis of PKR precursor Dienyne 105 
The synthetic plan towards (±)-sieboldine A 1 started with addition of allyl 
bromide to propargyl alcohol 83 in the presence of zinc dust and copper(I) iodide to 
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give alcohol 99 in 56% yield (Scheme 19).
61
 The alcohol 99 was subjected to Appel 
reaction conditions to form iododiene 100 in 71% yield.
57
 On the other hand, the 
hydroxyl group of commercially available 4-pentyn-1-ol 101 was protected with a 
PMB group to give pentyne 102 in 96% yield. Pentyne 102 was hydroxymethylated 
with n-BuLi and paraformaldehyde and the resulting alcohol was oxidized by 2-
iodoxybenzoic acid (IBX) in DMSO/THF mixture to give the desired aldehyde 103 in 
66 % yield. The iododiene 100 was entered into a Barbier reaction with aldehyde 103 
and the resulting secondary alcohol was protected with TBS group to form dienyne 
105. 
 
Scheme 19: Preparation of dienyne 105. 
2.1.3 Intramolecular PKR of Dienynes 104 and 105 
The intramolecular PKR of dienynes 104 and 105 using a catalytic amount of 
Co2(CO)8 in presence of tetramethylthourea (TMTU) under 1 atm of CO afforded 
indenones 106 and 107 (Table 1).
62-64
 An extremely high preferential formation of 
indenones 106 and 107 over 106' and 107' could tentatively be rationalized by 
considering the steric hindrance between the OR group and the carbon reside having 
PMB in the possible cobaltacyclic intermediates b and c. Dienyne 105 showed the 
best results in terms of diastereoselectivity and yield. The enhanced 
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diastereoselectivity in PKR of dienyne 105 compared to 104 might be attributed to the 







Table 1. Intramolecular PKR of dienynes 104 and 105. 
 
a
Ratio was calculated from isolated yields after column chromatography 
2.1.4 Stereoselective Reduction of indenone 107 
Entry Substrate R Temp (
o





1 104 H 70 89 89:11 
2 104 H 80 86 87:13 
3 105 TBS 70 96 98:2 
4 105 TBS 80 92 95:5 
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After obtaining indenone 107 with the required stereochemistry, our efforts 
moved towards the introduction of C15 methyl group and stereoselective reduction of 
the ketone group (Table 2). Hydrogenation of the exomethylene moiety of 107 in 
presence of 5 mol% Wilkinson's catalyst proceeded in a highly chemo- and 
stereoselective manner to form the methyl derivative 108 having the C15-methyl 
group with the desired stereochemistry in 98% yield.
57
 Stereoselective reduction of 
the ketone group was examined using K-selectride under different conditions, (Table 
2). Although the use of [18]-crown 6 as an additive during the reduction process had a 
beneficial effect on the yield, it decreased the stereoselectivity of the reduction. In 
addition, oxygenated solvents like Et2O and THF showed the best results in terms of 
yield and stereoselectivity over hydrocabon solvents as toluene.  
Table 2. Stereoselective reduction of ketone 108. 
 
Entry Solvent Additive Yield (%) dr 
a
 
1 Toluene ------------ 71 88:12 
2 THF ------------ 87 92:8 
3 Et2O ------------ 76 73:27 
4 Toluene [18]-crown-6 77 68:32 
5 THF [18]-crown-6 89 61:39 
a
Ratio calculated from isolated yields after column chromatography. 
2.1.5 Construction of the quaternary center and difficulties in removal of benzyl 
group 
The next synthetic steps aimed towards the construction of the all-carbon 
quaternary center by taking the advantage of the Ueno-Stork reaction (Scheme 20).
65-
69
 First, alcohol 109 was protected with a benzyl group in 83% yield. The TBS group 
of 110 was removed by TBAF and the resulting alcohol was reacted with ethyl 2-
bromovinyl ether in presence of acid catalysis to afford the bromoacetal 112. 
Treatment of 112 with tributyltin hydride under conventional radical initiation 
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conditions (AIBN in toluene) provided the cyclic acetal 113 in 73% yield of 2 steps 
with a dr of 3:1. The hemiacetal derivative, obtained from 113 by acid treatment, 
underwent a Wittig olefination reaction with PPh3MeBr and KHMDS to afford allyl 
alcohol 114 in 61% yield. Allyl alcohol 114 was protected with a MOM group to 
provide indene 115 in 91% yield. At this stage, we needed to remove the benzyl 
protecting group to restore the ketone functionality. Our attempts to obtain alcohol 
116 through radical reduction of indene 115 with lithium 4,4'-di-tert-butulbiphenylide  
(LiDBB)
70
 or lithium naphthalenide (LN)
71
 were unsuccessful. The encountered 
difficulties in removal of benzyl group through radical reduction may be attributed to 
the sterically congested environment surrounding the benzyl group. Accordingly, we 
decided to modify our strategy to form the oxa quaternary center before performing 
the Wittig olefination. 
 
Scheme 20: Preparation of 115 and attempts for benzyl deprotection. 
2.1.6 Attempts for silyl enolization of ketone 119 
The TBS group of 108 was removed by TBAF and the resulting alcohol 117 
was entered into the Ueno-Stork cascade to obtain the cyclic acetal 119 in 89% yield 
of 2 steps. We conceived that the formation of the oxa quaternary center could be 
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achieved through a Rubottom oxidation of the silyl enol derivative 120.
72
 We 
examined different protocols for preparation of the thermodynamically controlled 
silyl enol isomer 120 but our efforts were unfruitful (Table 3). The chlorosilanes were 
found to be unreactive enough for the conversion while the silyl triflates leaded to 







Table 3. Attempts for silyl enolization of ketone 119. 
Entry Conditions Solvent Temp. Time/h Result 
1 TMSCl, Mg THF rt to rf 24 No reaction 
2 TBSCl, Mg THF rt to rf 24 No Reaction 
3 TBSCl, Et3N DMF rt 24 No Reaction 
4 TBSCl, Et3N, NaI CH3CN rf 24 No reaction 
5 TMSOTf, Et3N CH2Cl2 0 
o
C to rt 2 Decomposed 




2.1.7 Regioselectivec acetate enolization ketone 119 
The acetate enolization of ketone 119 derivative proved to be more successful. 
we studied the acetate enolization process under weak basic catalysis, high reaction 
temperatures and long reaction times to favor the formation of the thermodynamically 





Table 4. Optimization of regioselective acetate enolization ketone 119. 
6 TBSOTf, Et3N CH2Cl2 0 
o
C to rt 2 Decomposed 
7 TBSOTf, 2,6-lutidine CH2Cl2 0 
o
C to rt 2 Decomposed 
Entry Conditions Temp(
o
C) Time/h Yield(%) 




The results showed that acetic anhydride was superior to acetyl chloride for 
the enolization of ketone 119. Aliphatic weak basic amines as Et3N were more 
successful in catalyzing the enolization process than their aromatic peers. The high 
regioselectivity was achieved by utilizing Ac2O and Et3N and DMAP and performing 
the reaction neat at 40 
o
C for 48 h to obtain acetate enol 121 in 92% yield. 
2.1.8 Preparation of Triol 125 
The oxidation of acetate enol 121 with m-CPBA occurred from the sterically 
less hindered α face, and the resulting acetoxy epoxide moiety was hydrolyzed to give 
the α-hydroxy ketone derivative 122 in 96% yield (Table 5). Ketone 122 was 
temporarily converted to the trans-diol derivative 123 in 86% yield by the 








P-TsOH Neat 110 24 16 












Neat 40 12 28 




Neat 40 8 58 
7 Ac2O (60) 
Et3N(30) 
,DMAP 
Neat 40 16 85 
8 Ac2O (60) 
Et3N(20) 
,DMAP 
Neat 40 48 92 
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chemical elaboration. The stereoselectivity observed in the K-selectride reduction of 
123 might be attributed to the attack of the bulky hydride donor from the sterically 
less-hindered α face again. Compound 123 was treated with PPTS, and the resulting 
hemiacetal 124 was subsequently subjected to the Wittig olefination to form the 
allyltriol 125. The polar nature of the Wittig olefination substrate triol 124 
necessitated the use of base formulated in oxygenated solvent rather than hydrocarbon 
solvent to optimize the yield of the reaction. 






2.1.9 Introduction of the nitrogen functionality 
Having established all the carbon units with the proper stereochemistry, we 
focused on the introduction of the nitrogen functionality (Scheme 21). The two 
secondary hydroxyl groups of the triol derivative 125 were protected with pivaloyl 
group to provide 126 in 71% yield, which was subjected to hydroboration with 
BH3.SMe2, followed by oxidation using NaBO3.4H2O to afford primary alcohol 127 
in 82% yield.
73
 The Mitsunobu reaction of 127 with protected hydroxyl amine 
Entry Base Temp. Time/h Yield 
1 n-BuLi (1.5 M in hexane) 0 
o
C to rt 18 18 
2 KHMDS (0.5 M in toluene) 0 
o
C to rt 18 45 
3 KHMDS (0.5 M in toluene) 0 
o
C to rf 8 Decomposed 
4 KHMDS (1.0 M in THF) 0 
o
C to rt 24 74 
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derivative Ns-NH-OMOM effected the introduction of the nitrogen atom to give 128 
in 88% yield.
74
 The PMB group of 128 was then removed with DDQ to afford the diol 
129 in 85% yield. 
 
 
Scheme 21: Preparation of diol 129. 
2.1.10 Optimized oxidation of Diol 129 
For the formation of the spirotetrahydrofuran ring, we visualized that a 
controlled oxidation of diol 129 into aldehyde 130 will be followed by a spontaneous 
nucleophilic attack of the tertiary hydroxyl to the aldehydic carbonyl and result in 
formation of the spirolactol derivative 131. We scanned the oxidation of diol 129 with 
different oxidant systems and the results are shown in Table 6. 
The periodinane reagents showed the best potential for oxidation of diol 129 in 
terms of yield. Optimization of oxidation of 129 by periodinanes was examined using 
gradually increasing equivalents of the oxidants to determine the best equivalent that 
provides the maximum yield of spirolactol 131 with minimum overoxidation to the 
lactone 131' (Table 7). We found that the oxidation of the diol 129 with 1.5 
equivalent of IBX in THF/DMSO (1:1) at room temperature provided a clean 
conversion to the spirolactol 131 in 83% yield without overoxidation to the 
corresponding lactone species. 
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 Solvent Temp. Time (h) Yield (%)
b
 
1 Dess-martin  CH2Cl2 0
 o
C to rt 3 45 
2 IBX THF/DMSO 0 
o
C to rt 6 51 




4 Swern DMSO -78
 o
C to rt 3 33
b
 
5 Parikh Doering DMSO rt 6 28 
6 SeO2 CH2Cl2 0
 o
C 26 26 
a
all Oxidants was used in 1.1 equivalent.  
b
SM was recovered in varying yields after column chromatography. 
Table 7. Optimization of oxidation of diol 129 with periodinanes. 
 














4 1.7 43 12 












9 1.7 74 5 
a
SM was recovered in varying yields after column chromatography. 
b
SM was recovered in 5 % yield sfter column chromatography. 




2.1.11 Assembly of the azacyclononane ring 
With the spirolactol 131 in hand, we examined the formation of the 
azacyclononane ring. The denosylation of 131 with thiophenolate smoothly proceeded 
to afford the aminolactol 132 in 90% yield. Aminolactol 132 possesses all of the 
necessary functional groups to form tetracyclic derivative 134. It was envisioned that 
treatment of 132 with Lewis or BrØnsted acids might remove the MOM group from 
the hydroxylamine, thereby freeing the hydroxylamine to react with oxocarbenium 
ion 133, generated under acidic reaction conditions, and assemble the nine-membered 
ring to form the tetracyclic derivative 134 (Table 8). 
Table 8. Attempts for formation of azacyclononane ring. 
 
Entry Condition Solvent Result 
1 MgSO4 CH2Cl2 No Reaction 
2 PPTS Pyridine Complex mixture 
2 ZnBr2 CH2Cl2 Decomposition 
3 TFA CH2Cl2 Decomposition 
4 TMSOTf CH2Cl2 Decomposition 
5 TMSI CH2Cl2 Decomposition 
6 PPh3,DEAD Toluene No Reaction 
7 Heat at 80 
o
C Toluene No Reaction 
 
Our efforts to induce dehydrative condensation of aminolactol 132 by MgSO4, 
or a combination of MgSO4 and ZnCl2, were unrewarded. Exposure of 132 to PPTS in 
pyridine resulted in complex reaction mixture. Moreover, Treatment of aminolactol 
132 with a variety of BrØnsted and Lewis acids resulted in complete destruction of the 
starting material (Table 8). We also explored the thermal dehydrative condensation 
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and Mitsunobu reaction conditions to promote the formation of azacyclononane ring 
but our attempts were unsuccessful. Our inability to form the N-
hydroxyazacyclononane ring under variety of conditions necessitated the search for 
milder reaction conditions to promote the condensation and complete the total 
synthesis of sieboldine A. We finally reached the conclusion that the Schmidt 
glycosylation condition was the best one for our purpose.
75-77
 Under Schmidt 
glycosylation conditions, aminolactol 132 would form the trichloroacetamidate 135 
which generate the oxocarbenium ion 136. Intramolecular nucleophilic attack of the N 
to C1 will assemble the azacyclononane ring. Indeed, treatment of aminolactol 132 
with Cl3CCN and DBU in CH2Cl2 at 0 °C to room temperature afforded the desired 
tetracyclic derivative 137 in 63% yield (Table 9). 





Temp. Time (h) Yield (%) 
1 3 0
 o
C to rt 18 31 
2 3 rt 18 22 
3 5 0
 o
C to rt 18 55 
4 10 0
 o
C to rt 48 63 
 
2.1.12 Completion of total synthesis of (±)-sieboldine A 1 
  33  
 
 
The final synthetic manipulations included removal of the protecting groups 
and restoring the ketone functionalities to complete the total synthesis of (±)-
sieboldine A 1. Optimization of the deprotection of Piv groups of 137 under different 
conditions is shown in table 10. The reductive cleavage with LAH showed the best 
results and afforded diol 138 in 92% yield. 
Table 10. Optimization of Piv deprotection of 137. 
 
 
Diol 138 was oxidized with DMP to furnish the diketone derivative 139 in 
72% yield. Finally, deprotection of the MOM protecting group with BBr3 delivered 
(±)-sieboldine A 1 in 73% yield . 
 
Scheme 22: Completion of total synthesis of (±)-sieboldine A 1. 
2.2 Total synthesis of (+)-Sieboldine A 
2.2.1 Retrosynthetic analysis of (+)-Sieboldine A 
Entry Condition Solvent Temp. Yield (%) 
1 DIBAL-H CH2Cl2 -78
o
C 63 
2 K2CO3 MeOH rf 42 
3 t-BuOK MeOH/H2O rt 45 
4 LAH THF 0
 o
C to rt 92 
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For the preparation of (+)-sieboldine A 1, we decided to follow the same 
synthetic steps explored in the racemic route with the exception of employing an 
optically pure dienyne 97 as a PKR substrate. In the racemic route, we prepared 
dienyne 97 through a Barbier coupling reaction between aldehyde 98 and iododiene 
100. For induction of chirality, we needed an enantioselective preparation of dienyne 
(+)-97 through the asymmetric allylation of aldehyde 98 with a suitable allyl 
derivative 140.  
 
Scheme 23: Retrosynthetic analysis of (+)-sieboldine A 1. 
The asymmetric allylation of aldehyde 98 is obviously one of the crucial steps 
in our synthesis. A parallel research at Mukai's group was concerned with the 













1 -CH=CH2 I In
0
, (+)-Ipc2BCl THF -78 
o
C to rt 7 75 








ee was determined by HPLC analysis (Daicel CHIRALPAK® OD-H). 
 
Several allyl derivatives and different asymmetric reaction conditions were 
evaluated to optimize the allylation process in terms of chemical yield and 
enantiomeric excess (Table 11). The results showed that (+)-97 could be prepared 
enantioselectively through a Keck asymmetric allylation of aldehyde 103 with allyl 
stannate derivatives.78 
 
2.2.2 Keck asymmetric allylation of aldehyde 103 
Allyl stannate 143 was prepared as described by trost et al.
79
 2-Methyl-2-
propen-1-ol 141 was reacted with n-BuLi, Bu3SnCl and TMEDA in a mixture of 
THF/Et2O and the resulting alcohol 142 was acetylated to afford allyl stannate 143 in 
51% yield of two steps. We also optimized the formation of aldehyde 103 from 4-
pentyn-1-ol 101 to be conducted in only 2 steps. First, 4-pentyn-1-ol 101 was 
protected by a PMB group to give pentyne 102 in 96% yield. Second, the direct 
formylation of 102 under conventional conditions
80
 gave the aldehyde 103 in 81% 
yield. 
2 -CH=CH2 I In
0
, (+)-Ipc2BCl THF -98 
o
C to rt 35 77 
3 -OTBDPS I In
0
, (+)-Ipc2BCl THF -78 
o
C to rt 15 75 





C to rt 80 89 





C to rt 80 93 




Scheme 24: Asymmetric allylation of aldehyde 103. 
The Keck asymmetric allylation of aldehyde 103 with allyl stannate 143 using 
the modified Ti(IV) catalyst described by Maruoka et al.
81
 proceeded smoothly and 
afforded hydroxyenyne (+)-144 in 80% yield with 93% ee. The (R)-absolute 
configuration of (+)-144 was established by NMR spectroscopic considerations based 
on the differences in chemical shift between the derived Mosher esters 145 and 146. 
2.2.3 Intramolecular PKR of Dienyne (+)-105 
The TBS protection of (+)-144 was followed by treatment with vinyl 
magnesium bromide to furnish dienyne (+)-105 in 85% yield of 2 steps. The highly 
diastereoselective PKR of (+)-105 was realized under catalytic conditions using 20 
mol% of Co2(CO)8 and 20 mol% of TMTU in toluene at 70 °C under 1 atm of CO to 
afford the indenone (-)-106 in 96% yield with dr of 98:2. 
Deprotection of the TBS group of (-)-106 with TBAF provided the alcohol (-)-
148, which was recrystallized from EtOAc/hexanes to furnish the optically pure (-)-
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148 in 90% yield (>99% ee). Fortuitously, alcohol (-)-148 was a crystalline solid and 




Scheme 25: Preparation of alcohol (-)-148. 
2.2.4  Synthesis of Triol (-)-125 
The hydrogenation of (-)-148 in the presence of Wilkinson’s catalyst afforded 
the methyl derivative (-)-117 in 98% yield. The Ueno-Stork cascade was applied to (-
)-117 to produce cyclic acetal (+)-119 in 91% yield with a dr of 3:1. Upon exposure to 
acetic anhydride in the presence of Et3N and DMAP at 40 °C, (+)-119 underwent 
regioselective acetate enolization to provide the vinyl acetate derivative (-)-121 in 
92% yield. The oxidation of (-)-121 with m-CPBA followed by base promoted 
hydrolysis gave the α-hydroxy ketone derivative (+)-122 in 96% yield. The ketone 
derivative (+)-122   was temporarily converted to the trans-diol derivative (-)-123 in 
86% yield by the stereoselective K-selectride reduction. Compound (+)-123 was 
treated with PPTS, and the resulting hemiacetal was subsequently subjected to the 
Wittig olefination with MePPh3Br to form the allyltriol (-)-125 in 55% yield. 




Scheme 26: Preparation of triol (-)-125. 
2.2.5  Synthesis of Aminolactol (-)-132 
The two secondary hydroxyl groups of triol (-)-125 were protected with 
pivaloyl group to provide (-)-126 in 71% yield, which was subjected to hydroboration 
followed by oxidation to afford primary alcohol (-)-127 in 82% yield. The Mitsunobu 
reaction of (-)-127 with NsNH-OMOM effected the introduction of the nitrogen atom 
to give (-)-128 in 88% yield. The PMB group of (-)-128 was then removed with DDQ 
to afford the diol (-)-129 in 85% yield. Controlled oxidation of (-)-127 with IBX 
furnished the spirolactol (-)-131 in 83% yield. The deprotection of nosyl group of (-)-
131 with thiophenolate produced the aminolactol (-)-132 in 90% yield. 
 




Scheme 27: synthesis of aminolactol (-)-132. 
2.2.6  Completion of total synthesis of (+)-sieboldine A 
The Schmidt glycosylation of aminolactol (-)-132 produced the desired 
tetracyclic derivative (+)-137 in 63% yield. LAH reduction of (+)-137 followed by 
oxidation with DMP furnished the diketone derivative. Finally, the MOM protecting 
group of the diketone derivative was removed by the commercially available BBr3, 
delivering (+)-sieboldine A 1 in 53% yield. The synthetic (+)-1 exhibited 




C NMR, IR, and HRMS) as well as optical 
rotation (observed [α]D 
24





Scheme 28: Completion of total synthesis of (+)-sieboldine A 1. 





In conclusion, we have completed the highly enantioselective total synthesis 
of (+)-sieboldine A 1 from 5-(pmethoxybenzyloxy)pentyne in 19 steps with a 1.9% 
overall yield. The key features of this synthesis include (i) enantioselective Keck 
allylation to form the optically active enyne (+)-144; (ii) PKR to build the 
bicyclo[4.3.0]nonenone fragment (-)-106 with a high diastereoselectivity; (iii) Ueno-
Stork cyclization to construct the cis-hydrindane skeleton with a carbon quaternary 
center; (iv) regioselective formation of the vinyl acetate moiety followed by oxidation 
with m-CPBA to form the oxa-quaternary center; (v) oxidative cyclization to prepare 
the spirolactol (-)-131; and (vi) Schmidt glycosylation for assembly of the N-
hydroxyazacyclononane ring. The enantioselective route for construction of the cis-
hydrindane core is convergent and flexible, thus providing new avenues to access 






















3.1 General notes 
All commercially obtained reagents and solvents were used as received unless 
additional purification is stated in the procedure. All glassware was oven-dried at 150 
°C and cooled in desiccator immediately before use. Experiments were conducted 
under inert atmospheres of Nitrogen or Argon using standard syringe–septa 
techniques. Reactions performed at room temperature were at approximately 24 °C. 
Thin layer chromatography (TLC) was performed on Merck analytical glass plates 
pre-coated with silica gel 60 F254 (0.25 mm thick). Visualization was effected by 
exposure to UV light (254 nm) and staining with p-anisaldehyde or phosphomolybdic 
acid stains followed by a brief heating on a hot plate. Concentration under reduced 
pressure was performed by rotary evaporation (~30 mmHg) at 20-40 °C. Flash 
column chromatography was performed as described by W. C. Still et al. (J. Org. 
Chem.1978, 43, 2923.) using forced flow of the indicated solvent system on Kanto
®
 
Chemical silica gel 60N (spherical, neutral, 40–50 µm,). Melting points were 
determined on YANAGIMOTO micro melting point apparatus and were uncorrected. 
Infrared spectra were recorded on a ThermoFisher Nicolet iS5 spectrometer and are 
reported in terms of frequency of absorption (cm
-1
). NMR spectra were recorded on 
JNM-ECS400 or JNM-ECA600 spectrometers. Chemical shift (δ) values are reported 
in parts per million relative to internal standard tetramethylsilane (δ 0.00 ppm) and 
residual CDCl3 (δ 7.27 ppm) for proton spectra and to residual CDCl3 (δ 77.23 ppm) 
for carbon spectra. Coupling constants are reported in Hertz. The following 
abbreviations were used for spin multiplicity: s, singlet; br s, broad singlet; d, doublet; 
t, triplet; q, quartet; dd, doublet of doublet; ddd, doublet of doublet of doublet; td, 
triplet of doublet; m, multiplet; br m, broad multiplet. High-resolution mass spectra 
were measured with JMS-T100TD (DART) mass spectrometer. Optical rotations were 
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measured with a JASCO P-2200 polarimeter with a sodium lamp and reported as 
followed: [α]TD (concentration g/100 mL, solvent). Single-crystal X-ray diffraction 
was measured with R-AXIS RAPID II. 
 
3.2 Synthetic procedures 
1-Methoxy-4-((pent-4-ynyloxy)methyl)benzene 102  
 
1-Methoxy-4-((pent-4-ynyloxy)methyl)benzene 102 was prepared from 4-





2-((Tributylstannyl)methyl)allyl acetate 143 
 
2-((Tributylstannyl)methyl)allyl acetate 143 was prepared from methallyl 





To a solution of alkyne 101 (10 g, 49 mmol) and hexamethylphosphoramide 
HMPA (21.5 mL, 122.5 mmol) in THF (100 mL) at -45 °C was added n-BuLi (1.43 
M in hexane, 51.5 mL, 73.5 mmol). After stirring for 30 min at the same temperature, 
DMF (15 mL, 196 mmol) was added at once and the reaction mixture was warmed up 
to room temperature over 1 h. The reaction was quenched with 10% aq KH2PO4 (270 
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mL) and the mixture was partitioned between EtOAc and brine. The layers were 
separated and the aqueous layer was extracted three times with EtOAc. The combined 
organic extracts were dried over anhydrous Na2SO4, filtered and concentrated under 
reduced pressure. The residue was purified by flash column chromatography using 
(hexanes/EtOAc, 6:1) as an eluent to afford aldehyde 103 as pale yellow oil (9.2 g, 
81% yield): 
1
H NMR (600 MHz, CDCl3); δ 9.11 (s, 1H), 7.24 (dd, J = 8.2, 4.1, 2H), 
6.86 (dd, J = 8.6, 4.3, 2H), 4.42 (s, 2H), 3.76 (s, 3H), 3.51 (t, J = 6.0, 2H), 2.51 (td, J 
= 7.0, 3.5, 2H), 1.85-1.84 (m, 2H); 
13
C NMR (151 MHz, CDCl3); δ 176.9, 159.0, 
130.0, 129.0, 113.5, 98.3, 81.5, 72.4, 67.5, 54.9, 27.5, 15.8; IR (thin film, cm
-1
) 2200, 
1664, 1243, 1030; DART HRMS m/z [M+H]
+





To a stirred solution of TiCl4 (22 μL, 0.2 mmol) in CH2Cl2 (3 mL) at 0 °C 
under argon was added Ti(Oi-Pr)4 (180 µL, 0.6 mmol). The reaction mixture was 
allowed to warm to room temperature and stirred for 1 h. Silver(I) oxide Ag2O (93 
mg, 0.4 mmol) was added and the reaction mixture was stirred for 5 h at the same 
temperature under exclusion of direct light. The reaction mixture was diluted with 
CH2Cl2 (8 mL), and (R)-BINOL (229 mg, 0.8 mmol) was added. After stirring for 2 h, 
the reaction mixture was cooled to -15 °C and a solution of aldehyde 103 (232 mg, 1 
mmol) in CH2Cl2 (2.5 mL) and a solution of allylstannane 143 (806 mg, 2 mmol) in 
CH2Cl2 (2.5 mL) were added sequentially via cannula. The reaction was allowed to 
warm to 0 °C and stirred at the same temperature for 10 h. The reaction mixture was 





was washed thoroughly with Et2O. The layers were 
separated and the aqueous layer was extracted three times with Et2O. The combined 
  44  
 
 
organic extracts were washed with water and brine, dried over anhydrous Na2SO4, 
filtered and concentrated under reduced pressure. The residue was purified by flash 
column chromatography using (hexanes/EtOAc, 2:1) as an eluent to afford alcohol 
(+)-144 as colorless oil (277 mg, 80% yield, 93% ee): [α]30D = +13.2 (c 1.1, CHCl3);  
1
H NMR (600 MHz, CDCl3); δ 7.25 (d, J = 8.6, 2H), 6.87 (d, J = 8.6, 2H), 5.17 (d, J = 
1.4, 1H), 5.09 (s, 1H), 4.58 (s, 2H), 4.48-4.46 (m, 1H), 4.43 (s, 2H), 3.79 (s, 3H), 3.50 
(t, J = 6.2, 2H), 2.58 (d, J = 5.2, 1H), 2.44 (d, J = 10.8, 2H), 2.31 (td, J = 7.1, 1.8, 
2H), 2.08 (s, 3H), 1.80-1.75 (m, 2H); 
13
C NMR (151 MHz, CDCl3); δ 170.6, 159.0, 
139.5, 130.3, 129.1, 115.9, 113.6, 85.0, 80.8, 72.4, 68.2, 66.7, 61.0, 55.1, 41.9, 28.5, 
20.8, 15.4; IR (thin film, cm
-1
) 3414, 1696, 1511, 1172; DART HRMS m/z [M+H]
+
 
calcd for C20H27O5 347.1858, found 347.1857; HPLC: Daicel CHIRALPAK
®
 OD-H 
column; λ = 254 nm; eluent: hexane/isopropanol = 90/10; flow rate: 1.0 mL/min; 
major enantiomer tR = 18.0 min, minor enantiomer tR = 20.2 min; ee = 93%.  
 (R)-4-((tert-Butyldimethylsilyl)oxy)-9-((4-methoxybenzyl)oxy)-2-methylenenon-
5-yn-1-yl acetate (+)-147 
 
To a solution of alcohol (+)-144 (3.1 g, 8.95 mmol) in CH2Cl2 (30 mL) were 
added imidazole (1.8 g, 26.85 mmol) and TBSCl (2.7 g, 17.9 mmol) at room 
temperature. After stirring for 4 h at the same temperature, the reaction mixture was 
quenched with water. The layers were separated and the aqueous layer was extracted 
three times with CH2Cl2. The combined organic layers were washed with brine, dried 
over anhydrous Na2SO4, filtered and concentrated under reduced pressure. The 
residue was chromatographed using (hexanes/EtOAc, from 10:1) as an eluent to 
afford (+)-147  as colorless oil (4.06 g, 99% yield): [α]30D = +22.9 (c 0.8, CHCl3);  
1
H 
NMR (400 MHz, CDCl3); δ 7.16 (d, J = 8.7, 2H), 6.78 (d, J = 8.7, 2H), 5.04 (d, J = 
1.4, 1H), 4.95 (s, 1H), 4.48 (s, 2H), 4.39-4.36 (m, 1H), 4.33 (s, 2H), 3.70 (s, 3H), 3.42 
(t, J = 6.4, 2H), 2.31 (d, J = 6.4, 2H),  2.20 (td, J = 7.3, 1.8, 2H), 1.99 (s, 3H), 1.69-
1.68 (m, 2H), 0.80 (s, 9H), 0.02 (s, 3H), 0.00 (s, 3H); 
13
C NMR (101 MHz, CDCl3); 
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δ170.5, 159.1, 139.9, 130.5, 129.1, 115.5, 113.7, 84.5, 81.3, 72.6, 68.5, 67.0, 62.4, 
55.1, 42.7, 28.7, 25.7, 20.9, 18.1, 15.5, -4.5, -5.1; IR (thin film, cm
-1
) 1733, 1514, 
1249, 1078; DART HRMS m/z [M+H]
+






yl)oxy)dimethylsilane (+)-105  
 
To a stirred solution of (+)-147 (2.3 g, 5 mmol) in THF (18 mL) and 
dimethylsulfide Me2S (1.8 mL) at room temperature under argon, was added CuI (190 
mg, 1.0 mmol). The reaction mixture was cooled to -30 °C, and vinylmagnesium 
bromide (10 mL, 10 mmol, 1.0 M in THF) was added slowly over 20 min. After 
stirring for 30 min at the same temperature, the reaction was quenched with saturated 
aq NaHCO3 and diluted with Et2O. The layers were separated and the aqueous layer 
was extracted three times with Et2O. The combined organic extracts were washed 
with water and brine, dried over anhydrous Na2SO4, filtered and concentrated under 
reduced pressure. The residue was purified by flash column chromatography using 
(hexanes/EtOAc, 20:1) as an eluent to afford dienyne (+)-105 as colorless oil (1.82 g, 
85%). [α]30D = +22.8 (c 0.9, CHCl3);  
1
H NMR (600 MHz, CDCl3); δ 7.14 (d, J = 8.6, 
2H), 6.76 (d, J = 8.6, 2H), 5.72-5.67 (m, 1H), 4.96-4.95 (m, 2H), 4.77-4.76 (m, 2H), 
4.36-4.35 (m, 1H), 4.32 (s, 2H), 3.66 (s, 3H), 3.41 (t, J = 6.4, 2H), 2.71 (d, J = 6.9, 
2H),  2.27-2.26 (m, 2H), 2.20 (td, J = 7.0, 1.7, 2H), 1.69-1.65 (m, 2H), 0.81 (s, 9H), 
0.03 (s, 3H), 0.00 (s, 3H); 
13
C NMR (151 MHz, CDCl3); δ 159.0, 143.7, 136.0, 130.4, 
129.0, 116.1, 113.5, 113.3, 84.0, 81.8, 72.5, 68.4, 62.3, 54.9, 45.1, 40.9, 28.7, 25.7, 
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18.1, 15.4, -4.6, -5.1; IR (thin film, cm
-1
) 2952, 1513, 1248, 1079; DART HRMS m/z 
[M+H]
+
 calcd for C26H41O3Si 429.2825, found 429.2827.  
(4R,7aS)-4-((tert-Butyldimethylsilyl)oxy)-3-(3-((4-methoxybenzyl)-oxy)propyl)-6-




To a stirred solution of dienyne (+)-105 (4.8 g, 11.2 mmol) in toluene (70 mL) 
were added Co2(CO)8 (766 mg, 20 mol %) and tetramethulthiourea TMTU (296 mg, 
20 mol %) at room temperature. The reaction was stirred for 4 h at 70 °C under 1 atm 
CO. The black suspension was concentrated under reduced pressure. The residue was 
chromatographed with (hexanes/EtOAc, 9:1) eluting first (-)-106 as colorless oil (4.8 
g, 94%) followed by (+)-106' as colorless oil (0.1 g, 2%). 
(4R,7aS)-4-((tert-Butyldimethylsilyl)oxy)-3-(3-((4-methoxybenzyl)-oxy)propyl)-
6-methylene-5,6,7,7a-tetrahydro-1H-inden-2(4H)-one (-)-106 
 [α]30D = -62.1 (c 1.0 , CHCl3);  
1
H NMR (600 MHz, 
CDCl3); δ 7.18 (d, J = 7.6, 2H), 6.79 (d, J = 7.6, 
2H), 4.82 (s, 2H), 4.71 (s, 1H), 4.34 (s, 2H), 3.72 (s, 
3H), 3.36-3.33 (m, 2H), 2.98-2.96 (m, 1H), 2.65 
(dd, J = 6.5, 3.4, 1H), 2.47 (dd, J = 19.2, 6.5, 1H), 
2.41 (d, J = 13.7, 1H),  2.23-2.22 (m, 2H), 2.09 (d, J 
= 13.7, 1H), 1.88 (d, J = 19.2, 1H) 1.71-1.70 (m, 
1H), 1.62-1.60 (m, 2H), 0.78 (s, 9H), 0.00 (s, 3H), -0.11 (s, 3H); 
13
C NMR (151 
MHz, CDCl3); δ 209.1, 173.9, 159.0, 141.8, 136.1, 130.5, 129.0, 113.6, 112.5, 72.3, 
69.1, 65.0, 55.1, 43.4, 43.3, 41.1, 36.6, 28.4, 25.5, 19.5, 17.9, -4.8, -4.9; IR (thin 
film, cm
-1
) 2928, 1702, 1247, 1071; DART HRMS m/z [M+H]
+
 calcd for 
C27H41O4Si 457.2774, found 457.2770. 
(4R,7aR)-4-((tert-Butyldimethylsilyl)oxy)-3-(3-((4-methoxy-benzyl)oxy)-propyl)-
6-methylene-5,6,7,7a-tetrahydro-1H-inden-2(4H)-one (+)-106' 
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 [α]25D = +21.0 (c 3.1 , CHCl3);  
1
H NMR (600 
MHz, CDCl3); δ 7.25-7.23 (m, 2H), 6.85 (d, J = 8.6, 
2H), 4.83 (s, 2H), 4.47 (dd, J = 11.7, 5.5, 1H), 4.41 
(d, J = 11.6, 1H), 4.39 (d, J = 11.6, 1H), 3.79 (s, 
3H), 3.42 (t, J = 7.0, 2H), 2.64-2.60 (m, 2H), 2.54-
2.52 (m, 3H),  2.48-2.45 (m, 1H), 2.24 (t, J = 11.9, 
1H), 1.96 (d, J = 17.2, 1H), 1.77-1.71 (m, 2H), 
1.64-1.62 (m, 1H), 0.92 (s, 9H), 0.13 (s, 3H), 0.11 (s, 3H); 
13
C NMR (151 MHz, 
CDCl3); δ 208.4, 173.0, 159.0, 143.2, 138.0, 130.8, 129.3, 113.6, 111.6, 74.3, 72.3, 
70.0, 55.2, 45.8, 42.8, 40.5, 39.1, 29.7, 25.9, 19.4, 18.2, -4.6, -5.0; IR (thin film, cm
-
1
) 2952, 1702, 1243, 1093; DART HRMS m/z [M+H]
+
 calcd for C27H41O4Si 






To a solution of indenone (-)-106 (1.63 g, 3.6 mmol) in THF (36 mL) at 
room temperature was added tetrabutylammonium fluoride TBAF (5.4 mL, 5.4 
mmol, 1.0 M in THF). After stirring for 3 h at the same temperature, the reaction 
was quenched with saturated aq NH4Cl and diluted by addition of EtOAc. The layers 
were separated and the aqueous layer was extracted three times with EtOAc. The 
combined organic extracts were washed with water and brine, dried over anhydrous 
Na2SO4, filtered and concentrated under reduced pressure. The residue was 
chromatographed with (hexanes/EtOAc, 2:1) as an eluent. The crude eluted fractions 
were evaporated and the remaining solid residue was recrystallized from 
(EtOAc/hexanes) to give (-)-148 as colorless needles (1.1 g, 90%, 99% ee): [α]30D = 
-117.7 (c 1.0 , CHCl3); mp = 68-69 °C; 
1
H NMR (600 MHz, CDCl3); δ 7.23 (d, J = 
8.6, 2H), 6.86 (d, J = 8.6, 2H), 4.98 (brs, 1H), 4.91-4.90 (m, 2H), 4.40 (d, J = 11.3, 
1H), 4.38 (d, J = 11.3, 1H), 3.79 (s, 3H), 3.41 (t, J = 6.2, 2H), 3.04-3.00 (m, 1H), 
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2.79 (d, J = 4.8, 1H), 2.73 (dd, J = 12.7, 4.5, 1H),  2.60-2.53 (m, 2H), 2.32-2.30 (m, 
3H), 1.97 (dd, J = 18.7, 1.9, 1H) 1.77-1.72 (m, 3H); 
13
C NMR (151 MHz, CDCl3); δ 
208.7, 172.8, 159.0, 141.6, 137.6, 130.1, 129.2, 113.7, 113.5, 72.0, 68.7, 64.2, 55.1, 
42.5, 42.0, 41.0, 36.7, 27.7, 19.2; IR (thin film, cm
-1
) 3411, 1697, 1512, 1247, 1036; 
DART HRMS m/z [M+H]
+
 calcd for C21H27O4 343.1909, found 343.1906; HPLC: 
Daicel CHIRALPAK
®
 OD-H column; λ = 254 nm; eluent: hexane/isopropanol = 




To a stirred solution of (-)-148 (5.5 g, 16 mmol) in benzene (60 mL) at room 
temperature was added RhCl(PPh3)3 (740 mg, 5 mol %). The reaction was stirred for 
6 h at room temperature under 1 atm H2. The brown mixture was concentrated under 
reduced pressure and the residue was chromatographed with (hexanes/EtOAc, 1:1) 
as an eluent to give (-)-117 as colorless oil (5.4 g, 98%): [α]25D = -80.4 (c 2.2 , 
CHCl3);  
1
H NMR (600 MHz, CDCl3); δ 7.22 (d, J = 8.6, 2H), 6.87 (d, J = 8.6, 2H), 
4.83 (brs, 1H),  4.40 (d, J = 11.7, 1H), 4.36 (d, J = 11.7, 1H), 3.80 (s, 3H), 3.41 (t, J 
= 5.3, 2H), 3.17-3.14 (m, 1H), 3.07 (s, 1H), 2.57 (dd, J = 18.9, 6.5, 1H), 2.31 (dd, J 
= 6.8, 6.5, 2H),  2.01-2.00 (m, 1H), 1.95-1.90 (m, 3H), 1.78-1.71 (m, 3H), 1.28-1.27 
(m, 4H); 
13
C NMR (151 MHz, CDCl3); δ 209.6, 175.1, 159.2, 137.4, 129.9, 129.3, 
113.7, 71.8, 68.4, 64.2, 55.2, 41.5, 40.2, 37.9, 31.0, 27.0, 26.9, 20.5, 19.1; IR (thin 
film, cm
-1
) 3426, 1701, 1512, 1174; DART HRMS m/z [M+H]
+
 calcd for C21H29O4 
345.2065, found 345.2064.  
(3aS,4R,6aS,8R,9aR)-2-Ethoxy-4-(3-((4-methoxybenzyl)oxy)propyl)-8-
methyloctahydroindeno[4,3a-b]furan-5(4H)-one (+)-119 




Pyridinium p-toluenesulfonate PPTS (263 mg, 1.05 mmol) and 
camphorsulfonic acid CSA (244 mg, 1.05 mmol) were added to a solution of alcohol 
(-)-117 (1.8 g, 5.23 mmol) and (Z/E)-2-bromovinyl ethyl ether
85
 (3.15 g, 20.9 mmol) 
at room temperature. After stirring for 2 h, the reaction was diluted by Et2O and 
quenched with saturated aq NaHCO3 at 0 °C. The layers were separated and the 
aqueous layer was extracted three times with Et2O. The combined organic layers 
were washed with water and brine, dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. The residue was passed through a short pad of 
silica gel using (hexanes/EtOAc, from 10:1 to 3:1) as an eluent. The crude eluted 
fractions were evaporated and dissolved in toluene. Tributyltin hydride n-Bu3SnH 
(7.0 mL, 26.15 mmol) and Azobisisobutyronitrile AIBN were added (0.43 g, 2.62 
mmol) at room temperature. The reaction was heated under reflux for 4 h. The 
solvent was evaporated under reduced pressure and the residue was 
chromatographed with (hexanes/EtOAc, from 6:1 to 2:1) to afford cyclic acetal (+)-
119 as colorless oil (1.97 g, 91%, two diastereomers, 3:1): [α]25D = +3.4 (c 1.9 , 
CHCl3);  
1
H NMR (600 MHz, CDCl3, major isomer); δ 7.25-7.24 (m, 2H), 6.87 (d, J 
= 8.6, 2H), 5.12 (dd, J = 5.7, 2.6, 1H),  4.41 (s, 2H), 3.95 (t, J = 5.3, 1H), 3.80 (s, 
3H), 3.75-3.71 (m, 1H), 3.46-3.41 (m, 3H), 2.44 (dd, J = 19.2, 8.9, 1H), 2.36-2.35 
(m, 1H), 2.26 (dd, J = 9.3, 4.8, 1H),  2.00-1.96 (m, 2H), 1.89-1.87 (m, 2H), 1.77-
1.73 (m, 2H), 1.68-1.64 (m, 1H), 1.53-1.45 (br m, 3H), 1.39-1.34 (m, 1H), 1.28-1.25 
(m, 1H), 1.17 (t, J = 7.0, 3H), 1.07 (d, J = 6.9, 3H); 
13
C NMR (151 MHz, CDCl3, 
major isomer); δ 219.4, 159.1, 130.6, 129.2, 113.7, 102.0, 78.7, 72.4, 69.9, 62.9, 
55.2, 52.3, 50.0, 42.1, 38.0, 33.8, 33.6, 33.4, 27.8, 24.9, 23.2, 20.7, 15.3; IR (thin 
film, cm
-1
) 2924, 1736, 1513, 1247, 1098; DART HRMS m/z [M+H]
+
 calcd for 
C25H37O5 417.2641, found 417.2639. 
(3aS,6aS,8R,9aR)-2-Ethoxy-4-(3-((4-methoxybenzyl)oxy)propyl)-8-methyl-
2,3,6,6a,7,8,9,9a-octahydroindeno[4,3a-b]furan-5-yl acetate (-)-121 




Dimethylaminopyridine DMAP (410.5 mg, 3.36 mmol) and Et3N (11.6 mL, 
84 mmol) were added to a solution of (+)-119 (3.5 g, 8.4 mmol) and acetic 
anhydride
 
(23.8 mL, 252 mmol) at room temperature. The reaction mixture was 
stirred at 40
 
°C for 48 h. The color changed from pale yellow to dark brown during 
the course of the reaction. The reaction was diluted by EtOAc at 0 °C and quenched 




 was washed thoroughly with EtOAc. The layers were separated and 
the aqueous layer was extracted three times with EtOAc. The combined organic 
layers were washed with saturated aq copper(II) sulfate and brine, dried over 
anhydrous Na2SO4, filtered and concentrated under reduced pressure. The residue 
was purified by column chromatography using (hexanes/EtOAc, from 9:1 to 6:1) as 
an eluent to afford vinyl acetate derivative (-)-121 as pale yellow oil (3.54 g, 92%, 
two diastereomers, 3:1): [α]24D = -13.1 (c 1.5, CHCl3);  
1
H NMR (600 MHz, CDCl3, 
major isomer); δ 7.26 (d, J = 8.6, 2H), 6.87 (d, J = 8.6, 2H), 5.11 (dd, J = 6.0, 3.3, 
1H),  4.41 (s, 2H), 4.05 (t, J = 4.6, 1H), 3.80 (s, 3H), 3.75-3.73 (m, 1H), 3.45-3.40 
(m, 3H), 2.57 (dd, J = 15.1, 7.9, 1H), 2.18-2.13 (br m, 5H), 2.08 (s, 3H), 1.92 (dd, J 
= 13.9, 3.3, 1H), 1.77-1.68 (m, 4H), 1.60-1.56 (m, 1H), 1.48-1.46 (m, 1H), 1.39-1.34 
(m, 1H), 1.17 (t, J = 7.0, 3H), 1.03 (d, J = 6.9, 3H); 
13
C NMR (151 MHz, CDCl3, 
major isomer); δ 168.7, 159.0, 146.1, 130.7, 129.1, 128.4, 113.7, 102.2, 78.0, 72.3, 
69.8, 63.1, 55.2, 54.1, 44.0, 39.0, 35.3, 33.7, 32.7, 28.5, 23.9, 21.7, 20.8, 20.5, 15.3; 
IR (thin film, cm
-1
) 3292, 1754, 1512, 1246, 1100; DART HRMS m/z [M+H]
+
 calcd 
for C27H39O6 459.2747, found 459.2749. 
(3aR,4R,6aS,8R,9aR)-2-Ethoxy-4-hydroxy-4-(3-((4-methoxybenzyl)-
oxy)propyl)-8-methyloctahydroindeno[4,3a-b]furan-5(4H)-one (+)-122 




To a solution of (-)-121 (2.0 g, 4.36 mmol) in CH2Cl2 (40 mL) at -20
 
°C was added a 
solution of m-CPBA
 
(2.26 g, 13.0 mmol) in CH2Cl2 (25 mL). The reaction mixture 
was gradually warmed to 0 °C and stirred for 2 h at the same temperature. The 
reaction was quenched with saturated aq NaHCO3 and Na2S2O3. The layers were 
separated and the aqueous layer was extracted three times with CH2Cl2. The 
combined organic layers were washed with water and brine, dried over anhydrous 
Na2SO4, filtered and concentrated under reduced pressure. The residue was 
dissolved in MeOH/H2O (15 mL: 1.5 mL). Potassium carbonate K2CO3 (241 mg, 
1.74 mmol) was added and the reaction mixture was stirred for 4 h at room 
temperature. The reaction mixture was partitioned between EtOAc and brine. The 
layers were separated and the aqueous layer was extracted three times with EtOAc. 
The combined organic layers were dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. The residue was purified by flash column 
chromatography using (hexanes/EtOAc, 4:1) as an eluent to give α-hydroxy ketone 
(+)-122 as colorless oil (1.8 g, 96% yield, two diastereomers, 3:1): [α]24D = +42.5 (c 
0.5, CHCl3);  
1
H NMR (400 MHz, CDCl3, major isomer); δ 7.23 (d, J = 8.7, 2H), 
6.87 (d, J = 8.7, 2H), 5.05 (dd, J = 6.4, 4.6, 1H),  4.94 (s, 1H), 4.49 (d, J = 11.4, 1H), 
4.42 (d, J = 11.4, 1H), 3.80 (s, 3H), 3.77-3.74 (m, 1H), 3.55-3.53 (m, 2H), 3.45-3.42 
(m, 2H), 2.83-2.80 (m, 1H), 2.71 (dd, J = 14.7, 6.4, 1H), 2.63 (dd, J = 19.5, 10.3, 
1H), 2.15-2.10 (m, 1H), 2.04-1.92 (m, 1H), 1.87-1.84 (m, 4H), 1.51-1.44 (m, 4H), 
1.35-1.31 (m, 1H), 1.21 (t, J = 7.1, 3H), 0.92 (d, J = 5.5, 3H); 
13
C NMR (151 MHz, 
CDCl3, major isomer); δ 215.8, 159.3, 129.6, 129.5, 113.8, 104.5, 80.4, 77.4, 72.7, 
70.8, 63.5, 56.0, 55.2, 39.5, 39.2, 34.8, 33.6, 32.9, 28.3, 24.0, 22.9, 21.9, 15.4; IR 
(thin film, cm
-1
) 3357, 1741, 1246, 1090; DART HRMS m/z [M+H]
+
 calcd for 
C25H37O6 433.25901, found 433.25905. 






K-Selectride (5.5 mL, 5.5 mmol, 1.0M solution in THF) was added dropwise 
to a solution of (+)-122 (1.8 g, 4.16 mmol) in THF (40 mL) at -45 °C under argon. 
After stirring for 6h at the same temperature, the reaction was quenched with 3 M aq 
NaOH and 30% aq H2O2. The mixture was diluted with EtOAc and the layers were 
separated. The aqueous layer was extracted three times with EtOAc. The combined 
organic extracts were washed with saturated aq Na2S2O3 and brine, dried over 
anhydrous Na2SO4, filtered and concentrated under reduced pressure. The residue 
was purified by flash column chromatography using (hexanes/EtOAc, from 2:1 to 
1:1) as an eluent to give trans-diol (-)-123 as colorless oil (1.54 g, 86% yield, two 
diastereomers, 3:1): [α]24D = -9.3 (c 0.8, CHCl3);  
1
H NMR (600 MHz, CDCl3); δ 
7.24-7.23 (m, 2H), 6.88-6.87 (m, 2H), 5.12-5.04 (m, 1H), 4.49-4.45 (m, 3H) 4.00-
3.98 (m, 1H), 3.80 (d, J = 10.0, 3H), 3.77-3.73 (m, 1H), 3.49-3.43 (m, 3H), 2.63-
2.62 (m, 1H), 2.54-2.48 (m, 2H), 2.41-2.38 (m, 1H), 2.15-2.08 (m, 2H), 1.83-1.76 
(m, 4H), 1.61-1.59 (m, 1H), 1.46-1.44 (m, 1H), 1.34-1.29 (m, 4H), 1.21-1.18 (m, 
3H), 0.91-0.89 (m, 3H); 
13
C NMR (151 MHz, CDCl3); δ 159.2, 129.6, 129.5, 129.4, 
113.8, 103.9, 102.4, 86.0, 85.6, 77.9, 77.4, 77.2, 72.9, 72.8, 70.6, 70.3, 63.4, 63.3, 
57.3, 55.2, 54.8, 40.0, 39.6, 38.4, 37.8, 37.4, 36.8, 36.2, 34.1, 34.0, 28.8, 27.5, 24.3, 
23.9, 23.8, 22.1, 22.0, 15.4; IR (thin film, cm
-1
) 3430, 1512, 1301, 1091; DART 
HRMS m/z [M+H]
+
 calcd for C25H39O6 435.2746, found 435.2742. 
(1R,2R,3aS,5R,7R,7aR)-7a-Allyl-1-(3-((4-methoxybenzyl)oxy)-propyl)-5-
methyloctahydro-1H-indene-1,2,7-triol (-)-125 




PPTS (123 mg, 0.49 mmol) was added to a solution of (-)-123 (1.06 g, 2.44 
mmol) in CH3CN/H2O (10 mL: 2 mL) at room temperature. The reaction mixture 
was heated under reflux for 4 h. The reaction was quenched with saturated aq 
NaHCO3 and the mixture was partitioned between EtOAc and brine. The layers were 
separated and the aqueous layer was extracted three times with EtOAc. The 
combined organic layers were dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. The residue was passed through a short pad of 
silica gel using (hexanes/EtOAc, 1:2) as an eluent. The crude eluted fractions were 
evaporated, dissolved in THF (10 mL) and cooled at 0°C. In a previously prepared 
second flask, methyltriphenylphosphonium bromide PPh3MeBr (6.1 g, 17.08 mmol) 
was dried at 80 °C under vacuum for 3 hours. After the salt has cooled THF (24 mL) 
was added and the slurry was cooled to 0 °C under argon. Potassium 
bis(trimehtylsilyl)amide KHMDS (16.8 mL, 16.8 mmol, 1.0 M in THF) was added 
dropwise at the same temperature resulting in a bright yellow color. After stirring for 
30 min at the same temperature, the bright yellow ylide slurry was cannulated to the 
first reaction flask at 0°C under argon. The reaction mixture was stirred at the same 
temperature for 2h then warmed gradually to room temperature and stirred 
overnight. The reaction was quenched with saturated aq NH4Cl and the mixture was 
diluted with EtOAc. The layers were separated and the aqueous layer was extracted 
three times with EtOAc. The combined organic extracts were washed with water and 
brine, dried over anhydrous Na2SO4, filtered and concentrated under reduced 
pressure. The residue was purified by flash column chromatography with 
(hexanes/EtOAc, 2:1) as eluent to afford triol (-)-125 as colorless oil (0.54 g, 55% 
yield): [α]24D = -13.4 (c 0.8, CHCl3);  
1
H NMR (600 MHz, CDCl3); δ 7.26-7.24 (m, 
2H), 6.87 (d, J = 9.3, 2H), 6.22-6.15 (m, 1H), 5.14 (dd, J = 17.2, 1.7, 1H), 5.03  (dd, 
J = 10.0, 1.7, 1H), 4.49 (d, J = 11.7, 1H), 4.46 (d, J = 11.7, 1H), 4.31-4.27 (m, 1H), 
3.94-3.93 (m, 1H), 3.80 (s, 3H), 3.57-3.54 (m, 1H), 3.46 (td, J = 8.5, 3.9, 1H), 3.33 
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(d, J = 2.7, 1H) 2.53-2.49 (m, 2H), 2.35-2.31 (m, 1H), 2.29-2.25 (m, 1H), 2.17 (s, 
1H), 2.15-2.10 (m, 1H), 1.93-1.88 (m, 1H), 1.84-1.80 (m, 2H), 1.75-1.74 (m, 1H), 
1.67-1.64 (m, 1H), 1.49-1.44 (m, 2H), 1.19-1.16 (m, 2H), 1.12-1.09 (m, 1H), 0.92 
(d, J = 6.5, 3H); 
13
C NMR (151 MHz, CDCl3); δ 159.3, 139.1, 129.8, 129.5, 116.5, 
113.8, 89.3, 77.8, 72.8, 70.1, 69.2, 55.2, 53.0, 41.3, 39.7, 36.0, 32.5, 32.1, 29.4, 25.6, 
24.0, 22.1; IR (thin film, cm
-1
) 3424, 1513, 1247, 1035; DART HRMS m/z [M+H]
+
 
calcd for C24H37O5 405.2641, found 405.2640. 
(2R,3R,3aR,4R,6R,7aS)-3a-Allyl-3-hydroxy-3-(3-((4-methoxybenzyl)-oxy)propyl)-
6-methyloctahydro-1H-indene-2,4-diyl bis(2,2-dimethyl-propanoate) (-)-126  
 
DMAP (35.5 mg, 0.29 mmol) and Et3N (8 mL, 58 mmol) were added to a 
solution of triol (-)-125 (235 mg, 0.58 mmol) in CH2Cl2 (4 mL) at room temperature. 
The reaction was cooled to 0 °C and pivaloyl chloride (7.1 mL, 58 mmol) was added 
dropwise. After the addition, the reaction was stirred at 0 °C for 1 h and then warmed 
to 40
 
°C and stirred for 48 h. The reaction mixture was diluted with CH2Cl2 at 0 °C 
and quenched with saturated aq NaHCO3. The layers were separated and the aqueous 
layer was extracted three times with CH2Cl2. The combined organic layers were 
washed with saturated aq copper(II) sulfate and brine, dried over anhydrous Na2SO4, 
filtered and concentrated under reduced pressure. The residue was purified by column 
chromatography using (hexanes/EtOAc, from 18:1 to 6:1) as an eluent to afford (-)-
126 as colorless oil (234.5 mg, 71% yield) ): [α]25D = -17.8 (c 3.3, CHCl3);  
1
H NMR 
(600 MHz, CDCl3); δ 7.22 (d, J = 8.6, 2H), 6.86 (d, J = 8.6, 2H), 6.19-6.15 (m, 1H), 
5.22 (dd, J = 11.5, 4.6, 1H), 5.12 (dd, J = 17.0, 1.5, 1H), 5.03 (dd, J = 10.1, 1.5, 1H), 
4.80 (dd, J = 8.2, 3.1, 1H), 4.42 (d, J = 11.3, 1H), 4.39 (d, J = 11.3, 1H), 3.80 (s, 3H), 
3.48-3.44 (m, 1H), 3.39 (br s, 1H), 3.34-3.30 (m, 1H), 2.65-2.63 (m, 1H), 2.55 (dd, J 
= 15.1, 7.2, 1H), 2.50-2.45 (m, 2H), 1.77-1.75 (m, 1H), 1.70-1.66 (m, 3H), 1.62-1.61 
(m, 1H), 1.46-1.43 (m, 2H), 1.35-1.31 (m, 2H), 1.21 (s, 9H), 1.17 (s, 9H), 1.11-1.06 
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(m, 1H), 0.90 (d, J = 6.5, 3H); 
13
C NMR (151 MHz, CDCl3); δ 177.4, 177.2, 159.2, 
138.3, 130.0, 129.3, 116.4, 113.7, 88.1, 79.0, 72.7, 72.4, 70.5, 55.2, 51.8, 40.1, 38.8, 
36.5, 35.5, 33.2, 32.6, 30.3, 27.1, 27.0, 26.8, 25.2, 24.0, 21.9; IR (thin film, cm
-1
) 
3443, 2924, 1721, 1158; DART HRMS m/z [M+H]
+






Borane dimethyl sulfide complex BH3.SMe2 (0.5 mL, 4.95 mmol) was added 
to a solution of allyl derivative (-)-126 (566 mg, 0.99 mmol) in THF (10 mL) at 0 °C 
under argon. After stirring for 2 h at the same temperature, water H2O (2 mL) and 
NaBO3.4H2O (762 mg, 4.95 mmol) were added. The reaction was warmed to room 
temperature and stirred for 4 h. The reaction mixture was partitioned between EtOAc 
and brine and the layers were separated. The aqueous layer was extracted three times 
with EtOAc. The combined organic layers were dried over anhydrous Na2SO4, 
filtered and concentrated under reduced pressure. The residue was chromatographed 
using (hexanes/EtOAc, from 2:1 to 1:1) as an eluent to afford primary alcohol (-)-127 
as colorless oil (480 mg, 82% yield): [α]25D = -19.8 (c 3.0, CHCl3);  
1
H NMR (600 
MHz, CDCl3); δ 7.23 (d, J = 8.2, 2H), 6.87 (d, J = 8.2, 2H), 5.21 (dd, J = 11.5, 4.6, 
1H), 4.81 (dd, J = 8.9, 3.4, 1H), 4.43 (d, J = 11.5, 1H), 4.39 (d, J = 11.5, 1H), 3.81 (s, 
3H), 3.64-3.63 (m, 2H), 3.50-3.47 (m, 2H), 3.33-3.31 (m, 1H), 2.65-2.62 (m, 1H), 
2.51-2.45 (m, 1H), 1.95-1.93 (m, 1H), 1.77-1.69 (m, 4H), 1.66-1.61 (m, 5H), 1.50-
1.48 (m, 2H), 1.32-1.26 (m, 3H), 1.21 (s, 9H), 1.16 (s, 9H), 0.89 (d, J = 6.5, 3H); 
13
C 
NMR (151 MHz, CDCl3); δ 177.4, 177.3, 159.3, 129.8, 129.4, 113.8, 87.9, 79.5, 72.8, 
72.7, 70.5, 64.3, 55.3, 50.9, 40.4, 38.8, 38.5, 36.6, 35.6, 33.5, 30.2, 29.2, 27.1, 26.8, 
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25.2, 24.6, 24.1, 21.9; IR (thin film, cm
-1
) 3426, 1721, 1284, 1156; DART HRMS m/z 
[M+H]
+
 calcd for C34H55O8 591.3897, found 591.3890. 
(2R,3R,3aR,4R,6R,7aS)-3-Hydroxy-3-(3-((4-methoxybenzyl)-oxy)propyl)-3a-(3-
(N-(methoxymethoxy)-2-nitrophenylsulfonamido)-propyl)-6-methyloctahydro-




 Ns-NH-OMOM (47 mg, 0.18 
mmol) and triphenylphosphine (168 mg, 0.64 mmol) were added to a solution of  
primary alcohol (-)-127  (94 mg, 0.16 mmol) in toluene (3 mL) at -20 °C. Diethyl 
azodicarboxylate DEAD (348 µL, 0.8 mmol, 40% in toluene) was added dropwise to 
the reaction mixture at the same temperature. The yellow suspension was warmed 
gradually to room temperature and stirred for 1 h. The orange suspension was 
concentrated under reduced pressure and the residue was chromatographed with 
(hexanes/Et2O, from 1:1 to 1:2) to afford (-)-128 as pale yellow oil (114 mg, 88%): 
[α]25D = -39.2 (c 1.5, CHCl3);  
1
H NMR (600 MHz, CDCl3); δ 8.04 (dd, J = 7.9, 1.0, 
1H), 7.79-7.72 (m, 2H), 7.59 (dd, J = 7.7, 1.2, 1H), 7.20 (d, J = 8.6, 2H), 6.86 (d, J = 
8.6, 2H), 5.19 (dd, J = 11.5, 4.6, 1H), 5.02 (d, J = 8.3, 1H), 4.99 (d, J = 8.3, 1H), 4.79 
(dd, J = 8.6, 3.1, 1H), 4.40 (d, J = 11.0, 1H), 4.38 (d, J = 11.0, 1H), 3.80 (s, 3H), 3.49-
3.44 (m, 1H), 3.43 (s, 3H), 3.33-3.32 (m, 1H), 3.24-3.23 (m, 2H), 2.62-2.58 (m, 1H), 
2.49-2.45 (m, 1H), 2.07-2.04 (m, 1H), 1.78-1.75 (m, 3H), 1.63-1.62 (m, 3H), 1.49-
1.43 (m, 2H), 1.29-1.26 (m, 4H), 1.21 (s, 9H), 1.15 (s, 9H), 1.10-1.06 (m, 2H), 0.89 
(d, J = 6.5, 3H); 
13
C NMR (151 MHz, CDCl3); δ 177.4, 177.3, 159.2, 149.8, 134.8, 
132.3, 130.9, 130.0, 129.2, 126.6, 123.8, 113.7, 102.7, 87.9, 79.3, 72.7, 72.6, 70.5, 
57.6, 55.3, 54.5, 51.0, 39.8, 38.8, 36.5, 35.5, 33.3, 30.2, 29.7, 27.1, 26.8, 25.5, 25.2, 
24.2, 23.2, 21.8; IR (thin film, cm
-1
) 3372, 2923, 1722, 1178; DART HRMS m/z 
[M+H]
+
 calcd for C42H63N2O13S  835.4051, found 835.4050. 





indene-2,4-diyl bis(2,2-dimethylpropanoate) (-)-129 
 
2,3-Dichloro-5,6-dicyano-1,4-benzoquinone DDQ (102 mg, 0.45 mmol) was added to 
a solution of (-)-128 (250 mg, 0.3 mmol) in CH2Cl2/H2O (4 mL: 1 mL) at room 
temperature. After stirring for 4 h at the same temperature, the reaction was quenched 
with saturated aq NaHCO3. The layers were separated and the aqueous layer was 
extracted three times with CH2Cl2. The combined organic layers were washed with 
H2O and brine, dried over anhydrous Na2SO4, filtered and concentrated under reduced 
pressure. The residue was purified by column chromatography using (hexane/EtOAc, 
from 1:1 to 1:2) as an eluent to afford diol (-)-129 as pale yellow oil (182 mg, 85% 
yield): [α]25D = -12.2 (c 0.22, CHCl3);  
1
H NMR (600 MHz, CDCl3); δ 8.05 (dd, J = 
7.9, 2.1, 1H), 7.82-7.79 (m, 1H), 7.77-7.76 (m, 1H), 7.60 (d, J = 7.9, 1H), 5.21 (dd, J 
= 11.5, 4.6, 1H), 5.06 (d, J = 7.9, 1H), 5.01 (d, J = 7.9, 1H), 4.82 (dd, J = 8.1, 2.9, 
1H), 3.70-3.68 (m, 1H), 3.55-3.53 (m, 1H), 3.47 (s, 3H), 3.28-3.21 (m, 3H), 2.62-2.59 
(m, 1H), 2.50-2.44 (m, 1H), 2.07-2.05 (m, 1H), 1.84-1.75 (m, 5H), 1.64-1.63 (m, 2H), 
1.50-1.44 (m, 2H), 1.34-1.25 (m, 3H), 1.22 (s, 9H), 1.18 (s, 9H), 1.11-1.09 (m, 2H), 
0.90 (d, J = 6.5, 3H); 
13
C NMR (151 MHz, CDCl3); δ 177.5, 177.3, 149.8, 134.9, 
132.3, 131.0, 126.6, 123.8, 102.7, 87.9, 79.2, 72.6, 63.3, 57.7, 54.5, 51.0, 39.9, 38.9, 
38.6, 36.5, 35.5, 33.3, 29.8, 27.1, 26.8, 25.4, 25.2, 23.1, 21.8, 14.2; IR (thin film, cm
-
1
) 3476, 1721, 1711, 1156; DART HRMS m/z [M+H]
+
 calcd for C34H55N2O12S  
715.3476, found 715.3472. 
 
 









 (29 mg, 0.105 mmol) was added to a solution of 
diol (-)-129 (49 mg, 0.07 mmol) in THF/DMSO (1.0 mL: 1.0 mL) at room 
temperature. After stirring for 6 h at the same temperature, the reaction was quenched 
with saturated aq NaHCO3 and partitioned between EtOAc and brine. The layers were 
separated and the aqueous layer was extracted three times with EtOAc. The combined 
organic layers were washed with brine, dried over anhydrous Na2SO4, filtered and 
concentrated under reduced pressure. The residue was purified by column 
chromatography using (hexanes/EtOAc, 1:1) as an eluent to afford spirolactol (-)-131 
as colorless oil (41.5 mg, 83% yield, two diastereomers, 3:1): [α]24D = -8.8 (c 0.24, 
CHCl3);  
1
H NMR (400 MHz, CDCl3); δ 8.08-8.05 (m, 1H), 7.79-7.74 (m, 2H), 7.61-
7.60 (m, 1H), 5.46-5.41 (m, 1H), 5.13-5.10 (m, 1H), 5.02-4.97 (m, 2H), 4.80-4.78 (m, 
1H), 3.47 (d, J = 11.0, 3H), 3.28-3.23 (m, 2H), 2.55-2.48 (m, 1H), 2.42-2.38 (m, 1H), 
2.21-2.17 (m, 1H), 2.11-2.03 (m, 1H), 1.81-1.77 (m, 4H), 1.70-1.65 (m, 4H), 1.54-
1.50 (m, 2H), 1.44-1.32 (m, 2H), 1.22 (d, J = 5.5, 9H), 1.17 (d, J = 1.8, 9H), 1.08-1.05 
(m, 1H), 0.91-0.89 (m, 3H); 
13
C NMR (101 MHz, CDCl3); δ 177.7, 177.3, 158.4, 
145.4, 134.8, 132.3, 132.0, 131.1, 123.9, 123.8, 102.3, 100.0, 99.3, 97.0, 78.1, 72.3, 
72.1, 57.8, 55.0, 48.8, 39.3, 38.8, 38.6, 36.1, 34.6, 33.2, 32.9, 31.8, 27.2, 27.1, 26.9, 
25.0, 24.3, 23.9, 23.4, 21.9; IR (thin film, cm
-1
) 3492, 1719, 1283, 1158; DART 
HRMS m/z [M+H]
+
 calcd for C34H53N2O12S  713.3319, found 713.3313. 
 
 







K2CO3 (29.0 mg, 0.21 mmol) and thiophenol PhSH (140 µL, 0.14 mmol, 1.0M in 
CH3CN) were added to a solution of (-)-131 (50 mg, 0.07 mmol) in CH3CN (4 mL) at 
room temperature. After stirring for 6 h at the same temperature, the mixture was 
partitioned between EtOAc and brine. The layers were separated and the aqueous 
layer was extracted three times with EtOAc. The combined organic layers were 
washed with brine, dried over anhydrous Na2SO4, filtered and concentrated under 
reduced pressure. The residue was purified by column chromatography using 
(hexanes/EtOAc, from 1:1 to 1:2) as an eluent to afford aminolactol (-)-132 as 
colorless oil (33.2 mg, 90% yield, two diastereomers, 3:1): [α]24D = -6.5 (c 0.4, 
CHCl3);  
1
H NMR (600 MHz, CDCl3); δ 5.44-5.43 (m, 1H), 5.11-5.09 (m, 1H), 4.82-
4.80 (m, 1H), 4.76 (d, J = 2.4, 2H), 3.42 (s, 3H), 3.18-3.16 (m, 1H), 2.92-2.87 (m, 
1H), 2.56-2.54 (m, 1H), 2.43-2.38 (m, 1H), 2.13-2.09 (m, 1H), 2.06-2.04 (m, 1H), 
1.84-1.75 (m, 5H), 1.70-1.63 (m, 2H), 1.54-1.52 (m, 2H), 1.43-1.38 (m, 1H), 1.27-
1.25 (m, 1H), 1.23 (d, J = 7.2, 9H), 1.17 (d, J = 9.3, 9H), 1.12-1.08 (m, 2H), 0.90-0.89 
(m, 4H); 
13
C NMR (151 MHz, CDCl3); δ 177.6, 177.3, 100.2, 99.2, 98.9, 97.0, 78.3, 
72.4, 55.9, 53.1, 48.7, 40.0, 39.3, 38.9, 38.6, 36.4, 34.7, 33.3, 33.2, 27.2, 27.1, 26.9, 
25.0, 24.5, 23.9, 23.0, 21.9; IR (thin film, cm
-1
) 3733, 1723, 1151; DART HRMS m/z 
[M+H]
+








5,7a-epoxyindeno[1,7a-e]azonine-8,13-diyl bis(2,2-dimethylpropanoate) (+)-137 
 
1,8-Diazabicyclo[5.4.0]undec-7-ene DBU (550 µL, 1.32 mmol, 2.4 M in 
CH2Cl2) was added dropwise to a solution of aminolactol (-)-132 (32.0 mg, 0.06 
mmol) in CH2Cl2 (4.0 mL) at 0 °C under argon. Trichloroacetonitrile (660 µL, 3.3 
mmol, 5.0 M in CH2Cl2) was added dropwise to the reaction mixture at the same 
temperature. After stirring at 0 °C for 2 h, the reaction mixture was gradually warmed 
to room temperature and stirred for 36 h. The color changed from pale yellow to dark 
brown during the course of the reaction. The dark brown solution was concentrated 
under reduced pressure and the residue was purified by flash chromatography using 
(hexanes/acetone, 40:3) as an eluent to afford tetracyclic derivative (+)-137 as a 
colorless film: (19.4 mg, 63% yield). [α]24D = +85.5 (c 0.33, CHCl3);  
1
H NMR (600 
MHz, CDCl3); δ 5.19 (dd, J = 11.5, 4.6, 1H), 5.09 (t, J = 5.7, 1H), 4.90 (dd, J = 8.9, 
3.6, 1H), 4.75 (s, 2H), 3.42 (s, 3H), 3.34-3.31 (m, 1H), 3.14-3.12 (m, 1H), 2.73-2.68 
(m, 1H), 2.47-2.41 (m, 1H), 2.37-2.33 (m, 1H), 2.21-2.16 (m, 1H), 2.01-1.96 (m, 4H), 
1.77-1.70 (m, 3H), 1.55-1.52 (m, 1H), 1.48-1.43 (m, 2H), 1.21 (s, 9H), 1.20 (s, 9H), 
1.16-1.15 (m, 2H), 0.89 (d, J = 6.2, 3H); 
13
C NMR (151 MHz, CDCl3); δ 177.8, 
177.0, 98.8, 96.5, 95.6, 80.5, 72.1, 56.1, 54.2, 49.5, 38.9, 38.6, 38.4, 35.2, 34.2, 31.3, 
29.0, 27.1, 26.9, 26.5, 25.2, 25.0, 21.9, 19.3; IR (thin film, cm
-1
) 2956, 1723, 1153; 
DART HRMS m/z [M+H]
+








 (+)-Sieboldine A 1 
 
Lithium aluminium hydride LAH (57 mg, 1.5 mmol) was added to a solution of (+)-
137 (11 mg, 0.021 mmol) in THF (3 mL) at 0 °C under argon. After stirring for 2 h at 
the same temperature, the reaction mixture was gradually warmed to room 
temperature and stirred for 18 h. The reaction was diluted with EtOAc at 0 °C and a 
saturated aq solution of Rochelle's salt was added. The mixture was allowed to warm 
to room temperature and stirred for 2h. The layers were separated and the aqueous 
layer was extracted three times with EtOAc. The combined organic layers were 
washed with H2O and brine, dried over anhydrous Na2SO4, filtered and concentrated 
under reduced pressure.  
The residue was dissolved in CH2Cl2 (3 mL). NaHCO3 (13 mg, 0.15 mmol)  and Dess 
martin periodinane DMP (0.5 mL, 0.15 mmol, 0.3 M in CH2Cl2) were added to the 
reaction mixture at room temperature under argon. After stirring for 2 h, the reaction 
was quenched with saturated aq NaHCO3. The layers were separated and the aqueous 
layer was extracted three times with CH2Cl2. The combined organic layers were 
washed with H2O and brine, dried over anhydrous Na2SO4, filtered and concentrated 
under reduced pressure.  
The residue was dissolved in CH2Cl2 (3 mL) and cooled to -78 °C under argon. Boron 
tribromide BBr3 (105 µL, 0.105 mmol, 1.0 M in CH2Cl2) was added dropwise to the 
reaction mixture at the same temperature. The reaction mixture was gradually warmed 
to 0 °C and stirred for 2 h and was then warmed to room temperature and stirred for 
18h. The reaction was quenched with saturated aq NaHCO3. The layers were 
separated and the aqueous layer was extracted three times with CH2Cl2. The 
combined organic layers were washed with H2O and brine, dried over anhydrous 
Na2SO4, filtered and concentrated under reduced pressure. The residue was purified 
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by flash chromatography using (hexanes/acetone, 1:1) as an eluent to afford (+)-
sieboldine A 1 as a colorless powder (3.3 mg, 53% yield): [α]25D = +140.0 (c 0.33, 
CH3OH);  
1
H NMR (600 MHz, CD3OD); δ; 4.89-4.87 (m, 1H), 3.27-3.22 (m, 1H), 
3.20-3.18 (m, 1H), 2.90 (ddd, J = 14.8, 7.4, 3.7, 1H), 2.57-2.55 (m, 1H), 2.51 (dd, J = 
12.9, 12.5, 1H), 2.47-2.45 (m, 1H), 2.43 (dd, J = 21.3, 10.7, 1H), 2.40-2.38 (m, 1H), 
2.11-2.10 (m, 1H), 2.08-2.07 (m, 1H), 2.05-2.04 (m, 1H), 2.03-2.01 (m, 1H), 1.98-
1.96 (m, 1H), 1.92 (dd, J = 19.6, 10.7, 1H), 1.79-1.77 (m, 2H), 1.76-1.75 (m, 1H), 
1.62-1.60 (m, 1H), 1.05 (d, J = 6.2, 3H); 
13
C NMR (151 MHz, CD3OD); δ 216.5, 
212.7, 98.5, 92.8, 62.3, 54.5, 47.6, 38.7, 37.2, 32.5, 31.8, 31.4, 28.3, 26.1, 22.5, 19.4; 
IR (thin film, cm
-1
) 3400, 1754, 1698; DART HRMS m/z [M+H]
+
 calcd for 
C16H24NO4  294.1705, found 294.1701. 
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3.3 Determination of the absolute configuration of (+)-144 
 
 
(R)-MTPA ester of (+)-144  (145) 
To a solution of (+)-144 (14 mg, 0.040 
mmol) in CH2Cl2 (0.40 mL) were added 
Et3N (50 µL, 0.36 mmol), DMAP (1.0 mg, 
8.0 x10
-3
 mmol) and (S)-MTPA-Cl (15 mg, 
6.0 x10
-2
 mmol) at room temperature. After 
stirring for 1.5 h at the same temperature, the reaction was quenched with saturated aq 
NH4Cl. The layers were separated and the aqueous layer was extracted three times 
with CH2Cl2. The combined organic extracts were dried over anhydrous Na2SO4, 
filtered and concentrated under reduced pressure. The residue was purified by flash 
column chromatography using (hexanes/EtOAc, 6:1) as an eluent to afford 145 (17 
mg, 75%) as a colorless oil: 
1
H NMR (400 MHz, CDCl3); δ 7.55-7.53 (m, 2H), 7.39-
7.36 (m, 3H), 7.26-7.23 (m, 2H), 6.88-6.86 (m, 2H), 5.71-5.68 (m, 1H), 5.09 (s, 1H), 
4.95 (s, 1H), 4.46-4.45 (m, 2H), 4.41 (s, 2H), 3.80 (s, 3H), 3.58 (s, 3H), 3.49 (t, J = 
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6.2, 2H), 2.58-2.49 (m, 2H), 2.33 (td, J = 7.1, 1.8, 2H), 2.07 (s, 3H), 1.81-1.74 (m, 
2H). 
 (S)-MTPA ester of (+)-144 (146) 
In the same manner as that described for 
preparation of 145, (+)-144 (14 mg, 0.040 
mmol) with (R)-MTPA-Cl (15 mg, 6.0 x 10
-2
 
mmol) afforded 146 (14 mg, 61 %) as a 
colorless oil: 
1
H NMR (400 MHz, CDCl3); δ 
7.53-7.51 (m, 2H), 7.40-7.35 (m, 3H), 7.26-7.23 (m, 2H), 6.89-6.85 (m, 2H), 5.70-
5.65 (m, 1H), 5.20 (s, 1H), 5.09 (s, 1H), 4.53 (s, 2H), 4.41 (s, 2H), 3.80 (s, 3H), 3.53 
(s, 3H), 3.48 (t, J = 6.2, 2H), 2.65-2.53 (m, 2H), 2.30 (td, J = 7.1, 1.8, 2H), 2.07 (s, 
3H), 1.78-1.72 (m, 2H). 
  
  65  
 
 
 3.4 Comparison of synthetic and natural (+)-sieboldine A spectral data 
3.4.1 (+)-Sieboldine A 
13
C spectra comparison: 
 
Position 
13C NMR (δ) 
Natural sample             
(CD3OD) 
13C NMR (δ) 
Synthetic sample 
(151 MHz, CD3OD) 
1 98.5 98.5 
2 31.4 31.4 
3 26.1 26.1 
4 92.8 92.8 
5 212.6 212.7 
6 37.2 37.2 
7 38.7 38.7 
8 31.8 31.8 
9 54.5 54.5 
10 19.4 19.4 
11 28.3 28.3 
12 62.3 62.3 
13 216.5 216.5 
14 47.4 47.6 
15 32.5 32.5 








3.4.2 (+)-Sieboldine A 
1
H spectra comparison: 
 
Position 
1H NMR (δ) 
Natural sample                 
(CD3OD) 
1H NMR (δ) 
Synthetic sample 
(600 MHz, CD3OD) 
1 4.89 (m, 1H) 4.89-4.87 (m, 1H) 
2a 1.98 (m, 1H) 1.98-1.96 (m, 1H) 
2b 2.12 (m, 1H) 2.11-2.10 (m, 1H) 
3a 2.08 (m, 1H) 2.08-2.07 (m, 1H) 
3b 2.40 (m, 1H) 2.40-2.38 (m, 1H) 
6a 1.93 (dd, J = 19.6, 10.9, 1H) 1.92 (dd, J = 19.6, 10.7, 1H) 
6b 2.45 (dd, J = 19.6, 9.2, 1H) 2.43 (dd, J = 21.3, 10.7, 1H) 
7 3.25 (m, 1H) 3.27-3.22 (m, 1H) 
8a 1.76 (m, 1H) 1.76-1.75 (m, 1H) 
8b 1.77 (m, 1H) 1.79-1.77 (m, 1H) 
9a 2.91 (ddd, J = 14.8, 8.0, 3.7, 1H) 2.90 (ddd, J = 14.8, 7.4, 3.7, 1H) 
9b 3.19 (m, 1H) 3.20-3.18 (m, 1H) 
10a 1.63 (m, 1H) 1.62-1.60 (m, 1H) 
10b 2.57 (m, 1H) 2.57-2.55 (m, 1H) 
11a 1.77 (m, 1H) 1.79-1.77 (m, 1H) 
11b 2.46 (m, 1H) 2.47-2.45 (m, 1H) 
14a 2.03 (m, 1H) 2.03-2.01 (m, 1H) 
14b 2.54 (dd, J = 12.7, 12.7, 1H) 2.51 (dd, J = 12.9, 12.5, 1H) 
15 2.06 (m, 1H) 2.05-2.04 (m, 1H) 
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OBFRQ       600.17 MHz
SLVNT CDCL3




































































220.0 210.0 200.0 190.0 180.0 170.0 160.0 150.0 140.0 130.0 120.0 110.0 100.0 90.0 80.0 70.0 60.0 50.0 40.0 30.0 20.0 10.0 0.0
OBNUC 13C
EXMOD single_pulse_dec
OBFRQ       150.92 MHz
SLVNT CDCL3































































































































































































10.0 9.0 8.0 7.0 6.0 5.0 4.0 3.0 2.0 1.0 0.0 -1.0
OBNUC 1H
EXMOD single_pulse.ex2
OBFRQ       600.17 MHz
SLVNT CDCL3
































































220.0 210.0 200.0 190.0 180.0 170.0 160.0 150.0 140.0 130.0 120.0 110.0 100.0 90.0 80.0 70.0 60.0 50.0 40.0 30.0 20.0 10.0 0.0
OBNUC 13C
EXMOD single_pulse_dec
OBFRQ       150.92 MHz
SLVNT CDCL3



















































































































9.0 8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5
OBNUC 1H
EXMOD single_pulse.ex2
OBFRQ       600.17 MHz
SLVNT CD3OD










































































































































































































































































































































































































































220.0 210.0 200.0 190.0 180.0 170.0 160.0 150.0 140.0 130.0 120.0 110.0 100.0 90.0 80.0 70.0 60.0 50.0 40.0 30.0 20.0 10.0 0.0
OBNUC 13C
EXMOD single_pulse_dec
OBFRQ       150.92 MHz
SLVNT CD3OD













































































































































  99  
 
 
                              
PPM
5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0
OBNUC 1H
EXMOD single_pulse.ex2
OBFRQ       600.17 MHz
SLVNT CD3OD





































































































































































































































220.0 210.0 200.0 190.0 180.0 170.0 160.0 150.0 140.0 130.0 120.0 110.0 100.0 90.0 80.0 70.0 60.0 50.0 40.0 30.0 20.0
OBNUC 13C
EXMOD single_pulse_dec
OBFRQ       150.92 MHz
SLVNT CD3OD
EXREF        49.00 ppm
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